'dysgammaglobulinémie'
(id=1832453 ; fe=dysgammaglobulinémie ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=17555 creation date=2015-07-30 touchdate=2025-12-02 05:16:53.000)

≈ 832 relations sortantes dysgammaglobulinémie -- r_associated #0: 50 / 1 -> dysgammaglobulinémies n1=dysgammaglobulinémie | n2=dysgammaglobulinémies | rel=r_associated | relid=0 | w=50 dysgammaglobulinémie -- r_associated #0: 40 / 0.8 -> déficit immunitaire n1=dysgammaglobulinémie | n2=déficit immunitaire | rel=r_associated | relid=0 | w=40 dysgammaglobulinémie -- r_associated #0: 40 / 0.8 -> dysglobulinémie n1=dysgammaglobulinémie | n2=dysglobulinémie | rel=r_associated | relid=0 | w=40 dysgammaglobulinémie -- r_associated #0: 35 / 0.7 -> processus pathologique n1=dysgammaglobulinémie | n2=processus pathologique | rel=r_associated | relid=0 | w=35 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormal b cell function n1=dysgammaglobulinémie | n2=en:abnormal b cell function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormal delayed hypersensitivity skin test n1=dysgammaglobulinémie | n2=en:abnormal delayed hypersensitivity skin test | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormal lymphocytic accumulation in non-lymphoid tissue n1=dysgammaglobulinémie | n2=en:abnormal lymphocytic accumulation in non-lymphoid tissue | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormal ratios of cd4+ helper t cells n1=dysgammaglobulinémie | n2=en:abnormal ratios of cd4+ helper t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormality of b cell physiology n1=dysgammaglobulinémie | n2=en:abnormality of b cell physiology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormality of t cells n1=dysgammaglobulinémie | n2=en:abnormality of t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abnormally large monocytes with vacuoles n1=dysgammaglobulinémie | n2=en:abnormally large monocytes with vacuoles | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abscess formation in any organ n1=dysgammaglobulinémie | n2=en:abscess formation in any organ | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abscesses are 'cold,' lacking erythema, heat, and swelling n1=dysgammaglobulinémie | n2=en:abscesses are 'cold,' lacking erythema, heat, and swelling | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of acetylcholine receptor (achr) autoantibodies n1=dysgammaglobulinémie | n2=en:absence of acetylcholine receptor (achr) autoantibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of anti-thyroid antibodies n1=dysgammaglobulinémie | n2=en:absence of anti-thyroid antibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of auto-antibodies to intrinsic factor or parietal cells n1=dysgammaglobulinémie | n2=en:absence of auto-antibodies to intrinsic factor or parietal cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of bactericidal oxidative 'respiratory burst' in phagocytes n1=dysgammaglobulinémie | n2=en:absence of bactericidal oxidative 'respiratory burst' in phagocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of cd3+ t cells (1 family) n1=dysgammaglobulinémie | n2=en:absence of cd3+ t cells (1 family) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of humoral and cellular immune response to foreign antigens n1=dysgammaglobulinémie | n2=en:absence of humoral and cellular immune response to foreign antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of lymph node germinal center n1=dysgammaglobulinémie | n2=en:absence of lymph node germinal center | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of pancreatic autoantibodies n1=dysgammaglobulinémie | n2=en:absence of pancreatic autoantibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absence of pus formation at site of infection n1=dysgammaglobulinémie | n2=en:absence of pus formation at site of infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent antibody production n1=dysgammaglobulinémie | n2=en:absent antibody production | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent b lymphocytes in all organs n1=dysgammaglobulinémie | n2=en:absent b lymphocytes in all organs | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent cd8+ t cells n1=dysgammaglobulinémie | n2=en:absent cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent cellular immunity n1=dysgammaglobulinémie | n2=en:absent cellular immunity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent delayed hypersensitivity skin test n1=dysgammaglobulinémie | n2=en:absent delayed hypersensitivity skin test | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent humoral immunity n1=dysgammaglobulinémie | n2=en:absent humoral immunity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent microvilli on the surface of peripheral blood lymphocytes n1=dysgammaglobulinémie | n2=en:absent microvilli on the surface of peripheral blood lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent mitogenic response n1=dysgammaglobulinémie | n2=en:absent mitogenic response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) n1=dysgammaglobulinémie | n2=en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent natural killer cell cytotoxicity n1=dysgammaglobulinémie | n2=en:absent natural killer cell cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent or reduced cd3+ cells n1=dysgammaglobulinémie | n2=en:absent or reduced cd3+ cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent or severely reduced numbers of b cells n1=dysgammaglobulinémie | n2=en:absent or severely reduced numbers of b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent or small dysplastic thymus n1=dysgammaglobulinémie | n2=en:absent or small dysplastic thymus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent peripheral blood b cells n1=dysgammaglobulinémie | n2=en:absent peripheral blood b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent peripheral blood t cells n1=dysgammaglobulinémie | n2=en:absent peripheral blood t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent plasma cells in all organs n1=dysgammaglobulinémie | n2=en:absent plasma cells in all organs | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent sialyl-lewis x ligand (slex) expression n1=dysgammaglobulinémie | n2=en:absent sialyl-lewis x ligand (slex) expression | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent specific antibody response n1=dysgammaglobulinémie | n2=en:absent specific antibody response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent t cells n1=dysgammaglobulinémie | n2=en:absent t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent t lymphocytes n1=dysgammaglobulinémie | n2=en:absent t lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absent thymus n1=dysgammaglobulinémie | n2=en:absent thymus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:absolute lymphocyte count decreased n1=dysgammaglobulinémie | n2=en:absolute lymphocyte count decreased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:abundant cd4+ t cells n1=dysgammaglobulinémie | n2=en:abundant cd4+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients n1=dysgammaglobulinémie | n2=en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:acquired immunodeficiency n1=dysgammaglobulinémie | n2=en:acquired immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:acquired immunodeficiency syndrome n1=dysgammaglobulinémie | n2=en:acquired immunodeficiency syndrome | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:activated hla dr+ t cells in peripheral blood n1=dysgammaglobulinémie | n2=en:activated hla dr+ t cells in peripheral blood | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:activated mononuclear phagocytes n1=dysgammaglobulinémie | n2=en:activated mononuclear phagocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:activated t-helper cells n1=dysgammaglobulinémie | n2=en:activated t-helper cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:activation of the alternative complement pathway and depletion of complement components n1=dysgammaglobulinémie | n2=en:activation of the alternative complement pathway and depletion of complement components | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:activation of the complement system n1=dysgammaglobulinémie | n2=en:activation of the complement system | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:agammaglobulinemia n1=dysgammaglobulinémie | n2=en:agammaglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:allergic to dogs n1=dysgammaglobulinémie | n2=en:allergic to dogs | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:alpha/beta, cd4-/cd8- t cells are minimally or not increased n1=dysgammaglobulinémie | n2=en:alpha/beta, cd4-/cd8- t cells are minimally or not increased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:altered t-cell regulation n1=dysgammaglobulinémie | n2=en:altered t-cell regulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:angioedema n1=dysgammaglobulinémie | n2=en:angioedema | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antibody n1=dysgammaglobulinémie | n2=en:antibody | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antibody-dependent cellular cytotoxicity of nk cells is unaffected n1=dysgammaglobulinémie | n2=en:antibody-dependent cellular cytotoxicity of nk cells is unaffected | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antigen n1=dysgammaglobulinémie | n2=en:antigen | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antigenically defective c8 detected n1=dysgammaglobulinémie | n2=en:antigenically defective c8 detected | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antinuclear antibody present (in some patients) n1=dysgammaglobulinémie | n2=en:antinuclear antibody present (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antinuclear antibody present, speckled pattern n1=dysgammaglobulinémie | n2=en:antinuclear antibody present, speckled pattern | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antinuclear autoantibodies (in some) n1=dysgammaglobulinémie | n2=en:antinuclear autoantibodies (in some) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:antithrombin iii deficiency n1=dysgammaglobulinémie | n2=en:antithrombin iii deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:aplasia of thymus gland with immunodeficiency n1=dysgammaglobulinémie | n2=en:aplasia of thymus gland with immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:armed macrophage n1=dysgammaglobulinémie | n2=en:armed macrophage | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:arrest of b cell development at very early stage n1=dysgammaglobulinémie | n2=en:arrest of b cell development at very early stage | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:aspects of mortality statistics n1=dysgammaglobulinémie | n2=en:aspects of mortality statistics | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:aspects of radionuclide imaging n1=dysgammaglobulinémie | n2=en:aspects of radionuclide imaging | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:aspergillus infections n1=dysgammaglobulinémie | n2=en:aspergillus infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid n1=dysgammaglobulinémie | n2=en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) n1=dysgammaglobulinémie | n2=en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) n1=dysgammaglobulinémie | n2=en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) n1=dysgammaglobulinémie | n2=en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:association with autoimmune diseases n1=dysgammaglobulinémie | n2=en:association with autoimmune diseases | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:asthma n1=dysgammaglobulinémie | n2=en:asthma | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:atopic disorders (eczema, food allergy, asthma) n1=dysgammaglobulinémie | n2=en:atopic disorders (eczema, food allergy, asthma) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) n1=dysgammaglobulinémie | n2=en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoantibodies (in some patients) n1=dysgammaglobulinémie | n2=en:autoantibodies (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoantibodies, transient n1=dysgammaglobulinémie | n2=en:autoantibodies, transient | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoantibody n1=dysgammaglobulinémie | n2=en:autoantibody | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmune disease n1=dysgammaglobulinémie | n2=en:autoimmune disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmune disease (in some patients) n1=dysgammaglobulinémie | n2=en:autoimmune disease (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmune disease resembling systemic lupus erythematosis (sle, 152700) (in about 26%) n1=dysgammaglobulinémie | n2=en:autoimmune disease resembling systemic lupus erythematosis (sle, 152700) (in about 26%) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) n1=dysgammaglobulinémie | n2=en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmune disorders (in some patients) n1=dysgammaglobulinémie | n2=en:autoimmune disorders (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmune features (in some patients) n1=dysgammaglobulinémie | n2=en:autoimmune features (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoimmunity to pancreatic beta cells (rare) n1=dysgammaglobulinémie | n2=en:autoimmunity to pancreatic beta cells (rare) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoinflammation, systemic n1=dysgammaglobulinémie | n2=en:autoinflammation, systemic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:autoinflammatory disorders n1=dysgammaglobulinémie | n2=en:autoinflammatory disorders | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:b and t cell defects (reported in 2 sibs) n1=dysgammaglobulinémie | n2=en:b and t cell defects (reported in 2 sibs) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:b cells lack surface cd19 and cd81 expression n1=dysgammaglobulinémie | n2=en:b cells lack surface cd19 and cd81 expression | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:b cells lack surface cd19 expression n1=dysgammaglobulinémie | n2=en:b cells lack surface cd19 expression | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:b cells lack surface cd20 expression n1=dysgammaglobulinémie | n2=en:b cells lack surface cd20 expression | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:b-cell lymphocytosis n1=dysgammaglobulinémie | n2=en:b-cell lymphocytosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:b-lymphocyte immunodeficiency n1=dysgammaglobulinémie | n2=en:b-lymphocyte immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:biopsy shows lipid-laden macrophages n1=dysgammaglobulinémie | n2=en:biopsy shows lipid-laden macrophages | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:block at the pro-b to pre-b stage of differentiation n1=dysgammaglobulinémie | n2=en:block at the pro-b to pre-b stage of differentiation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:block of b-cell differentiation n1=dysgammaglobulinémie | n2=en:block of b-cell differentiation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:blood protein disorders n1=dysgammaglobulinémie | n2=en:blood protein disorders | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:bone marrow shows lymphoid hyperplasia n1=dysgammaglobulinémie | n2=en:bone marrow shows lymphoid hyperplasia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:burkholderia cepacia infection n1=dysgammaglobulinémie | n2=en:burkholderia cepacia infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:c1q deficiency n1=dysgammaglobulinémie | n2=en:c1q deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:c1q molecule present, but dysfunctional n1=dysgammaglobulinémie | n2=en:c1q molecule present, but dysfunctional | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:c2 deficiency n1=dysgammaglobulinémie | n2=en:c2 deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:c8 deficiency n1=dysgammaglobulinémie | n2=en:c8 deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cancer immunology n1=dysgammaglobulinémie | n2=en:cancer immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cd4/cd8 ratio decreased n1=dysgammaglobulinémie | n2=en:cd4/cd8 ratio decreased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cd4+ t-cell lymphopenia n1=dysgammaglobulinémie | n2=en:cd4+ t-cell lymphopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cd40 ligand deficiency n1=dysgammaglobulinémie | n2=en:cd40 ligand deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cells show impaired immunologic responses to immune stimulation n1=dysgammaglobulinémie | n2=en:cells show impaired immunologic responses to immune stimulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cellular immunodeficiency n1=dysgammaglobulinémie | n2=en:cellular immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cellular immunology n1=dysgammaglobulinémie | n2=en:cellular immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cellulitis due to immunodeficiency n1=dysgammaglobulinémie | n2=en:cellulitis due to immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:chemically induced n1=dysgammaglobulinémie | n2=en:chemically induced | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:childhood-onset systemic lupus erythematosus n1=dysgammaglobulinémie | n2=en:childhood-onset systemic lupus erythematosus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:chronic human papillomavirus (hpv) infection n1=dysgammaglobulinémie | n2=en:chronic human papillomavirus (hpv) infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:chronic mucocutaneous candidiasis n1=dysgammaglobulinémie | n2=en:chronic mucocutaneous candidiasis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:chronic viral infections (1 patient) n1=dysgammaglobulinémie | n2=en:chronic viral infections (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:circulating immune complexes n1=dysgammaglobulinémie | n2=en:circulating immune complexes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:circulating t and b cells are naive n1=dysgammaglobulinémie | n2=en:circulating t and b cells are naive | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:clinical immunology n1=dysgammaglobulinémie | n2=en:clinical immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:combined humoral and cellular immunodeficiency n1=dysgammaglobulinémie | n2=en:combined humoral and cellular immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:combined immunodeficiency (reported in 1 patient) n1=dysgammaglobulinémie | n2=en:combined immunodeficiency (reported in 1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:combined variable immunodeficiency involving b and t cells n1=dysgammaglobulinémie | n2=en:combined variable immunodeficiency involving b and t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:common variable immunodeficiency n1=dysgammaglobulinémie | n2=en:common variable immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:complement component consumption n1=dysgammaglobulinémie | n2=en:complement component consumption | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:complement deficiency n1=dysgammaglobulinémie | n2=en:complement deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:complication aspects n1=dysgammaglobulinémie | n2=en:complication aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital agammaglobulinemia n1=dysgammaglobulinémie | n2=en:congenital agammaglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital blood protein disorder n1=dysgammaglobulinémie | n2=en:congenital blood protein disorder | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital combined immunodeficiency n1=dysgammaglobulinémie | n2=en:congenital combined immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital disorder of natural immunity n1=dysgammaglobulinémie | n2=en:congenital disorder of natural immunity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital hypoplasia of thymus n1=dysgammaglobulinémie | n2=en:congenital hypoplasia of thymus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital immunodeficiency disease n1=dysgammaglobulinémie | n2=en:congenital immunodeficiency disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:congenital mesh qualifier n1=dysgammaglobulinémie | n2=en:congenital mesh qualifier | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:continuous activation of the alternative complement pathway n1=dysgammaglobulinémie | n2=en:continuous activation of the alternative complement pathway | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cow's milk protein sensitivity n1=dysgammaglobulinémie | n2=en:cow's milk protein sensitivity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cutaneous anergy n1=dysgammaglobulinémie | n2=en:cutaneous anergy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:cytokine defects n1=dysgammaglobulinémie | n2=en:cytokine defects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased b cell survival and tolerance n1=dysgammaglobulinémie | n2=en:decreased b cell survival and tolerance | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased b cells n1=dysgammaglobulinémie | n2=en:decreased b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd19+ b cells n1=dysgammaglobulinémie | n2=en:decreased cd19+ b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd27+ b cells n1=dysgammaglobulinémie | n2=en:decreased cd27+ b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd3 complex n1=dysgammaglobulinémie | n2=en:decreased cd3 complex | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd3 expression on t cells n1=dysgammaglobulinémie | n2=en:decreased cd3 expression on t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd3(-)cd16/15(+) natural killer cells n1=dysgammaglobulinémie | n2=en:decreased cd3(-)cd16/15(+) natural killer cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd3+ cells subset n1=dysgammaglobulinémie | n2=en:decreased cd3+ cells subset | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd4+ and cd3+/cd4+ lymphocytes n1=dysgammaglobulinémie | n2=en:decreased cd4+ and cd3+/cd4+ lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd4+ cells subset n1=dysgammaglobulinémie | n2=en:decreased cd4+ cells subset | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd4+ t cells n1=dysgammaglobulinémie | n2=en:decreased cd4+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd4+cd45ra+ t cells n1=dysgammaglobulinémie | n2=en:decreased cd4+cd45ra+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd8+ cells subset n1=dysgammaglobulinémie | n2=en:decreased cd8+ cells subset | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cd8+ t cells n1=dysgammaglobulinémie | n2=en:decreased cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cellular caspase-8 levels n1=dysgammaglobulinémie | n2=en:decreased cellular caspase-8 levels | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulating b cells n1=dysgammaglobulinémie | n2=en:decreased circulating b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulating b cells (total cd19+) n1=dysgammaglobulinémie | n2=en:decreased circulating b cells (total cd19+) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulating cd4+ t cells n1=dysgammaglobulinémie | n2=en:decreased circulating cd4+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) n1=dysgammaglobulinémie | n2=en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulating naive t cells (1 family) n1=dysgammaglobulinémie | n2=en:decreased circulating naive t cells (1 family) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulating nk cells n1=dysgammaglobulinémie | n2=en:decreased circulating nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased circulation t cells n1=dysgammaglobulinémie | n2=en:decreased circulation t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased cytotoxic activity of cd8+ t cells n1=dysgammaglobulinémie | n2=en:decreased cytotoxic activity of cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased differentiated b cells n1=dysgammaglobulinémie | n2=en:decreased differentiated b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased effector t cells n1=dysgammaglobulinémie | n2=en:decreased effector t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased iga, plasma and secretory n1=dysgammaglobulinémie | n2=en:decreased iga, plasma and secretory | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased immunoglobulin g (igg) n1=dysgammaglobulinémie | n2=en:decreased immunoglobulin g (igg) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased invariant nk t cells n1=dysgammaglobulinémie | n2=en:decreased invariant nk t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased itk protein in lymphoid tissue n1=dysgammaglobulinémie | n2=en:decreased itk protein in lymphoid tissue | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased levels of naive t cells n1=dysgammaglobulinémie | n2=en:decreased levels of naive t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) n1=dysgammaglobulinémie | n2=en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased memory b cells n1=dysgammaglobulinémie | n2=en:decreased memory b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased memory b cells (in some patients) n1=dysgammaglobulinémie | n2=en:decreased memory b cells (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased memory b cells, progressive n1=dysgammaglobulinémie | n2=en:decreased memory b cells, progressive | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased naive cd4+ and cd8+ t cells n1=dysgammaglobulinémie | n2=en:decreased naive cd4+ and cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased neutrophil and monocyte migration and chemotaxis n1=dysgammaglobulinémie | n2=en:decreased neutrophil and monocyte migration and chemotaxis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased nk cells, particularly nk cell precursors n1=dysgammaglobulinémie | n2=en:decreased nk cells, particularly nk cell precursors | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased nk levels (in some patients) n1=dysgammaglobulinémie | n2=en:decreased nk levels (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased number of cd8+ t cells n1=dysgammaglobulinémie | n2=en:decreased number of cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased number of tcr alpha/beta+ t cells n1=dysgammaglobulinémie | n2=en:decreased number of tcr alpha/beta+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of b cells n1=dysgammaglobulinémie | n2=en:decreased numbers of b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of long-term memory cd8+ t cells n1=dysgammaglobulinémie | n2=en:decreased numbers of long-term memory cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of mature b cells n1=dysgammaglobulinémie | n2=en:decreased numbers of mature b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of naive cd4+ and cd8+ t cells n1=dysgammaglobulinémie | n2=en:decreased numbers of naive cd4+ and cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of natural killer cells (nk) n1=dysgammaglobulinémie | n2=en:decreased numbers of natural killer cells (nk) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of nk cells n1=dysgammaglobulinémie | n2=en:decreased numbers of nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of t cells n1=dysgammaglobulinémie | n2=en:decreased numbers of t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased numbers of thymus emigrant cells n1=dysgammaglobulinémie | n2=en:decreased numbers of thymus emigrant cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased or absent pre-b cells n1=dysgammaglobulinémie | n2=en:decreased or absent pre-b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased or normal numbers of nk cells n1=dysgammaglobulinémie | n2=en:decreased or normal numbers of nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased percentage of igd- igm- cd27+ class-switched memory b cells n1=dysgammaglobulinémie | n2=en:decreased percentage of igd- igm- cd27+ class-switched memory b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased percentage of igd+ igm+ cd27+ memory b cells n1=dysgammaglobulinémie | n2=en:decreased percentage of igd+ igm+ cd27+ memory b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased regulatory t cells n1=dysgammaglobulinémie | n2=en:decreased regulatory t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum complement c3 n1=dysgammaglobulinémie | n2=en:decreased serum complement c3 | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum complement c3 (120700) n1=dysgammaglobulinémie | n2=en:decreased serum complement c3 (120700) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum complement factor b (cfb, 138470) n1=dysgammaglobulinémie | n2=en:decreased serum complement factor b (cfb, 138470) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum complement factor h (cfh, 134370) n1=dysgammaglobulinémie | n2=en:decreased serum complement factor h (cfh, 134370) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum complement factor i n1=dysgammaglobulinémie | n2=en:decreased serum complement factor i | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum iga n1=dysgammaglobulinémie | n2=en:decreased serum iga | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased serum igm n1=dysgammaglobulinémie | n2=en:decreased serum igm | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased specific antibodies n1=dysgammaglobulinémie | n2=en:decreased specific antibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t cell activation n1=dysgammaglobulinémie | n2=en:decreased t cell activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t cell production of cytokines n1=dysgammaglobulinémie | n2=en:decreased t cell production of cytokines | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t cell proliferation n1=dysgammaglobulinémie | n2=en:decreased t cell proliferation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t cell response to mitogens n1=dysgammaglobulinémie | n2=en:decreased t cell response to mitogens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t cell-dependent antibody production n1=dysgammaglobulinémie | n2=en:decreased t cell-dependent antibody production | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t cells n1=dysgammaglobulinémie | n2=en:decreased t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t-cell proliferative response to mitogens n1=dysgammaglobulinémie | n2=en:decreased t-cell proliferative response to mitogens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:decreased t-cell proliferative responses in vitro n1=dysgammaglobulinémie | n2=en:decreased t-cell proliferative responses in vitro | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defect in v(d)j recombination process n1=dysgammaglobulinémie | n2=en:defect in v(d)j recombination process | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective antibody production n1=dysgammaglobulinémie | n2=en:defective antibody production | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective antibody production against polysaccharide-based vaccines n1=dysgammaglobulinémie | n2=en:defective antibody production against polysaccharide-based vaccines | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective antibody production, particularly t-cell-independent n1=dysgammaglobulinémie | n2=en:defective antibody production, particularly t-cell-independent | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective antibody response n1=dysgammaglobulinémie | n2=en:defective antibody response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective b cell activation n1=dysgammaglobulinémie | n2=en:defective b cell activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective b cell differentiation n1=dysgammaglobulinémie | n2=en:defective b cell differentiation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective cd8+ t cell function n1=dysgammaglobulinémie | n2=en:defective cd8+ t cell function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective complement regulation n1=dysgammaglobulinémie | n2=en:defective complement regulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective generation of somatic hypermutations (shm) n1=dysgammaglobulinémie | n2=en:defective generation of somatic hypermutations (shm) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective humoral response n1=dysgammaglobulinémie | n2=en:defective humoral response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective il21r-related signaling n1=dysgammaglobulinémie | n2=en:defective il21r-related signaling | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective intracellular signaling in lymphocytes n1=dysgammaglobulinémie | n2=en:defective intracellular signaling in lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective lymphocyte apoptosis n1=dysgammaglobulinémie | n2=en:defective lymphocyte apoptosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective macrophage function n1=dysgammaglobulinémie | n2=en:defective macrophage function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective natural killer cell (nk) activation n1=dysgammaglobulinémie | n2=en:defective natural killer cell (nk) activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective neutrophil function n1=dysgammaglobulinémie | n2=en:defective neutrophil function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective nk function in spontaneous cellular cytotoxicity n1=dysgammaglobulinémie | n2=en:defective nk function in spontaneous cellular cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective response of b and t cells to activation n1=dysgammaglobulinémie | n2=en:defective response of b and t cells to activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:defective t cell function n1=dysgammaglobulinémie | n2=en:defective t cell function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity n1=dysgammaglobulinémie | n2=en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:deltaretrovirus infections n1=dysgammaglobulinémie | n2=en:deltaretrovirus infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:depleted cd4+ t cells n1=dysgammaglobulinémie | n2=en:depleted cd4+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:depletion of components of the alternative complement pathway n1=dysgammaglobulinémie | n2=en:depletion of components of the alternative complement pathway | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dermatomyositis n1=dysgammaglobulinémie | n2=en:dermatomyositis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dermatomyositis (in 1 patient) n1=dysgammaglobulinémie | n2=en:dermatomyositis (in 1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dermatophytic lymphadenitis (in some patients) n1=dysgammaglobulinémie | n2=en:dermatophytic lymphadenitis (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:developmental arrest of b cells at the pre-b to pro-b cell transition stage n1=dysgammaglobulinémie | n2=en:developmental arrest of b cells at the pre-b to pro-b cell transition stage | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:developmental immunology n1=dysgammaglobulinémie | n2=en:developmental immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:diagnosis aspect n1=dysgammaglobulinémie | n2=en:diagnosis aspect | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens n1=dysgammaglobulinémie | n2=en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dysfunctional alternative complement pathway n1=dysgammaglobulinémie | n2=en:dysfunctional alternative complement pathway | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dysfunctional nk cells n1=dysgammaglobulinémie | n2=en:dysfunctional nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dysglobulinemia n1=dysgammaglobulinémie | n2=en:dysglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:dysplasia of thymus gland with immunodeficiency n1=dysgammaglobulinémie | n2=en:dysplasia of thymus gland with immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:ectopic thymus n1=dysgammaglobulinémie | n2=en:ectopic thymus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:elevated iga (equal to or greater than 2.6g/l) n1=dysgammaglobulinémie | n2=en:elevated iga (equal to or greater than 2.6g/l) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:elevated igd n1=dysgammaglobulinémie | n2=en:elevated igd | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:elevated immunoglobulins, particularly ige n1=dysgammaglobulinémie | n2=en:elevated immunoglobulins, particularly ige | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:elevated levels of serum ige n1=dysgammaglobulinémie | n2=en:elevated levels of serum ige | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:elevated polyclonal igd (equal to or greater than 100 iu/ml) n1=dysgammaglobulinémie | n2=en:elevated polyclonal igd (equal to or greater than 100 iu/ml) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:enterovirus infections n1=dysgammaglobulinémie | n2=en:enterovirus infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:environmental illness n1=dysgammaglobulinémie | n2=en:environmental illness | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:enzymology n1=dysgammaglobulinémie | n2=en:enzymology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:epidemiologic n1=dysgammaglobulinémie | n2=en:epidemiologic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:epilepsy telangiectasia n1=dysgammaglobulinémie | n2=en:epilepsy telangiectasia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:erythrophagocytosis in late phase n1=dysgammaglobulinémie | n2=en:erythrophagocytosis in late phase | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:escherichia coli infection n1=dysgammaglobulinémie | n2=en:escherichia coli infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:ethnologic n1=dysgammaglobulinémie | n2=en:ethnologic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:etiology aspects n1=dysgammaglobulinémie | n2=en:etiology aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:evidence of ebv infection n1=dysgammaglobulinémie | n2=en:evidence of ebv infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:exposure as collected domain n1=dysgammaglobulinémie | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:extrahepatic reticuloendothelial system spared n1=dysgammaglobulinémie | n2=en:extrahepatic reticuloendothelial system spared | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:few mature neutrophils in the bone marrow n1=dysgammaglobulinémie | n2=en:few mature neutrophils in the bone marrow | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:food allergies (in some patients) n1=dysgammaglobulinémie | n2=en:food allergies (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:food allergy n1=dysgammaglobulinémie | n2=en:food allergy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:foot infections leading to amputation n1=dysgammaglobulinémie | n2=en:foot infections leading to amputation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:foot ulcer n1=dysgammaglobulinémie | n2=en:foot ulcer | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent bacterial, fungal and viral infections n1=dysgammaglobulinémie | n2=en:frequent bacterial, fungal and viral infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent bacterial, viral, and opportunistic infections n1=dysgammaglobulinémie | n2=en:frequent bacterial, viral, and opportunistic infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent bacterial, viral, protozoan, and fungal infections n1=dysgammaglobulinémie | n2=en:frequent bacterial, viral, protozoan, and fungal infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent fungal, viral, and opportunistic infections n1=dysgammaglobulinémie | n2=en:frequent fungal, viral, and opportunistic infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent illnesses n1=dysgammaglobulinémie | n2=en:frequent illnesses | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent infections in childhood n1=dysgammaglobulinémie | n2=en:frequent infections in childhood | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:frequent infections t-lymphocyte dysfunction, rare n1=dysgammaglobulinémie | n2=en:frequent infections t-lymphocyte dysfunction, rare | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:fulminant infectious mononucleosis n1=dysgammaglobulinémie | n2=en:fulminant infectious mononucleosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:fungal infection n1=dysgammaglobulinémie | n2=en:fungal infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:gammopathy n1=dysgammaglobulinémie | n2=en:gammopathy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:gata2 deficiency n1=dysgammaglobulinémie | n2=en:gata2 deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:generalized enlarged lymph nodes n1=dysgammaglobulinémie | n2=en:generalized enlarged lymph nodes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:genetic aspects n1=dysgammaglobulinémie | n2=en:genetic aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:giant germinal centers in lymph nodes n1=dysgammaglobulinémie | n2=en:giant germinal centers in lymph nodes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:granulocyte dysfunction (1 patient) n1=dysgammaglobulinémie | n2=en:granulocyte dysfunction (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:granuloma formation n1=dysgammaglobulinémie | n2=en:granuloma formation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:granulomas can appear on skin, tongue, lungs, or other tissues n1=dysgammaglobulinémie | n2=en:granulomas can appear on skin, tongue, lungs, or other tissues | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hashimoto thyroiditis n1=dysgammaglobulinémie | n2=en:hashimoto thyroiditis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:heavy chain disease n1=dysgammaglobulinémie | n2=en:heavy chain disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hemoglobinopathy n1=dysgammaglobulinémie | n2=en:hemoglobinopathy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hemophagocytosis (in some patients) n1=dysgammaglobulinémie | n2=en:hemophagocytosis (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hemophagocytosis in bone marrow and lymph nodes n1=dysgammaglobulinémie | n2=en:hemophagocytosis in bone marrow and lymph nodes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hepatic abscesses due to immunodeficiency n1=dysgammaglobulinémie | n2=en:hepatic abscesses due to immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:herpes simplex virus infection, mucocutaneous n1=dysgammaglobulinémie | n2=en:herpes simplex virus infection, mucocutaneous | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:herpesviridae infections n1=dysgammaglobulinémie | n2=en:herpesviridae infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen n1=dysgammaglobulinémie | n2=en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:historical aspects qualifier n1=dysgammaglobulinémie | n2=en:historical aspects qualifier | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hiv infection n1=dysgammaglobulinémie | n2=en:hiv infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hla antigens cw6, b13, b17 associated with psoriasis n1=dysgammaglobulinémie | n2=en:hla antigens cw6, b13, b17 associated with psoriasis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:humoral deficiency (likely result of t-cell abnormalities) n1=dysgammaglobulinémie | n2=en:humoral deficiency (likely result of t-cell abnormalities) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyper iga (in some patients) n1=dysgammaglobulinémie | n2=en:hyper iga (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyper-igm immunodeficiency syndrome, type 1 n1=dysgammaglobulinémie | n2=en:hyper-igm immunodeficiency syndrome, type 1 | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypereosinophilia n1=dysgammaglobulinémie | n2=en:hypereosinophilia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypergammaglobulinemia n1=dysgammaglobulinémie | n2=en:hypergammaglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypergammaglobulinemia (in some patients) n1=dysgammaglobulinémie | n2=en:hypergammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyperglobulinemia n1=dysgammaglobulinémie | n2=en:hyperglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyperinflammatory disorder n1=dysgammaglobulinémie | n2=en:hyperinflammatory disorder | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyperinflammatory state (in some patients) n1=dysgammaglobulinémie | n2=en:hyperinflammatory state (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyperplasia of tonsils n1=dysgammaglobulinémie | n2=en:hyperplasia of tonsils | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyperproliferation of effector t cells n1=dysgammaglobulinémie | n2=en:hyperproliferation of effector t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hyperproteinemia n1=dysgammaglobulinémie | n2=en:hyperproteinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypersensitivity n1=dysgammaglobulinémie | n2=en:hypersensitivity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypogammaglobulinemia n1=dysgammaglobulinémie | n2=en:hypogammaglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypogammaglobulinemia (1 patient) n1=dysgammaglobulinémie | n2=en:hypogammaglobulinemia (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypogammaglobulinemia (in some patients) n1=dysgammaglobulinémie | n2=en:hypogammaglobulinemia (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypogammaglobulinemia, profound n1=dysgammaglobulinémie | n2=en:hypogammaglobulinemia, profound | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypoglobulinemia result n1=dysgammaglobulinémie | n2=en:hypoglobulinemia result | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypoimmunoglobulinemia n1=dysgammaglobulinémie | n2=en:hypoimmunoglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypomorphic rag1 deficiency n1=dysgammaglobulinémie | n2=en:hypomorphic rag1 deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypoplastic thymus which often lacks hassal corpuscles n1=dysgammaglobulinémie | n2=en:hypoplastic thymus which often lacks hassal corpuscles | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:hypoproteinemia n1=dysgammaglobulinémie | n2=en:hypoproteinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:ifn-gamma receptor 1 deficiency n1=dysgammaglobulinémie | n2=en:ifn-gamma receptor 1 deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:ige deficiency n1=dysgammaglobulinémie | n2=en:ige deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:igg deficiency n1=dysgammaglobulinémie | n2=en:igg deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:igg, decreased n1=dysgammaglobulinémie | n2=en:igg, decreased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:igm deficiency n1=dysgammaglobulinémie | n2=en:igm deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:igm immunodeficiency (in some patients) n1=dysgammaglobulinémie | n2=en:igm immunodeficiency (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:il6 continuously elevated (in some patients) n1=dysgammaglobulinémie | n2=en:il6 continuously elevated (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immune defect due to a t cell deficit n1=dysgammaglobulinémie | n2=en:immune defect due to a t cell deficit | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immune dysregulation n1=dysgammaglobulinémie | n2=en:immune dysregulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immune response process n1=dysgammaglobulinémie | n2=en:immune response process | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunity n1=dysgammaglobulinémie | n2=en:immunity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunocompromised n1=dysgammaglobulinémie | n2=en:immunocompromised | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency (in some patients) n1=dysgammaglobulinémie | n2=en:immunodeficiency (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency disorders nec n1=dysgammaglobulinémie | n2=en:immunodeficiency disorders nec | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency of unknown origin n1=dysgammaglobulinémie | n2=en:immunodeficiency of unknown origin | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency with hyper-igm n1=dysgammaglobulinémie | n2=en:immunodeficiency with hyper-igm | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency with thymoma n1=dysgammaglobulinémie | n2=en:immunodeficiency with thymoma | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency, primarily affecting b cell line n1=dysgammaglobulinémie | n2=en:immunodeficiency, primarily affecting b cell line | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunodeficiency, severe combined (in some patients) n1=dysgammaglobulinémie | n2=en:immunodeficiency, severe combined (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunogenetics n1=dysgammaglobulinémie | n2=en:immunogenetics | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunoglobulin a decreased n1=dysgammaglobulinémie | n2=en:immunoglobulin a decreased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunoglobulin a deficiency (disorder) n1=dysgammaglobulinémie | n2=en:immunoglobulin a deficiency (disorder) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunoglobulin deficiency (iga, igg, igm) n1=dysgammaglobulinémie | n2=en:immunoglobulin deficiency (iga, igg, igm) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunohematology n1=dysgammaglobulinémie | n2=en:immunohematology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunologic evaluation unremarkable n1=dysgammaglobulinémie | n2=en:immunologic evaluation unremarkable | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunology n1=dysgammaglobulinémie | n2=en:immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunology aspects n1=dysgammaglobulinémie | n2=en:immunology aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunology, other n1=dysgammaglobulinémie | n2=en:immunology, other | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunophenotyping n1=dysgammaglobulinémie | n2=en:immunophenotyping | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunoregulation n1=dysgammaglobulinémie | n2=en:immunoregulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunosecretory disorder n1=dysgammaglobulinémie | n2=en:immunosecretory disorder | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:immunotoxicity n1=dysgammaglobulinémie | n2=en:immunotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired b cell class-switching n1=dysgammaglobulinémie | n2=en:impaired b cell class-switching | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired b cell memory cells n1=dysgammaglobulinémie | n2=en:impaired b cell memory cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired b-cell differentiation n1=dysgammaglobulinémie | n2=en:impaired b-cell differentiation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired cellular and humoral immunity n1=dysgammaglobulinémie | n2=en:impaired cellular and humoral immunity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired ig class switch recombination n1=dysgammaglobulinémie | n2=en:impaired ig class switch recombination | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired lymphocyte proliferation response to malignancy n1=dysgammaglobulinémie | n2=en:impaired lymphocyte proliferation response to malignancy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired seroconversion of immunoglobulins in response to vaccination n1=dysgammaglobulinémie | n2=en:impaired seroconversion of immunoglobulins in response to vaccination | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired signaling through the t-cell receptor n1=dysgammaglobulinémie | n2=en:impaired signaling through the t-cell receptor | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired survival of mature t cells n1=dysgammaglobulinémie | n2=en:impaired survival of mature t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired t cell activation n1=dysgammaglobulinémie | n2=en:impaired t cell activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired t cell function n1=dysgammaglobulinémie | n2=en:impaired t cell function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired t cell immunity n1=dysgammaglobulinémie | n2=en:impaired t cell immunity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired t cell proliferation and activation n1=dysgammaglobulinémie | n2=en:impaired t cell proliferation and activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired t cell proliferative response n1=dysgammaglobulinémie | n2=en:impaired t cell proliferative response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:impaired t-cell proliferation to certain stimuli n1=dysgammaglobulinémie | n2=en:impaired t-cell proliferation to certain stimuli | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:in blood n1=dysgammaglobulinémie | n2=en:in blood | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:in cerebrospinal fluid n1=dysgammaglobulinémie | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:in urine n1=dysgammaglobulinémie | n2=en:in urine | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:inability to mount antibody response to antigen n1=dysgammaglobulinémie | n2=en:inability to mount antibody response to antigen | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:inability to reject allogenic cells n1=dysgammaglobulinémie | n2=en:inability to reject allogenic cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:inborn immunodeficiency n1=dysgammaglobulinémie | n2=en:inborn immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increase in b cell number n1=dysgammaglobulinémie | n2=en:increase in b cell number | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increase in b cells (in some patients) n1=dysgammaglobulinémie | n2=en:increase in b cells (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation n1=dysgammaglobulinémie | n2=en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased activated cd8+ t cells n1=dysgammaglobulinémie | n2=en:increased activated cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased alpha-interferon activity n1=dysgammaglobulinémie | n2=en:increased alpha-interferon activity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased cd21+ (low) b cells n1=dysgammaglobulinémie | n2=en:increased cd21+ (low) b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased circulating transitional b cells (cd19+cd38+igm+) n1=dysgammaglobulinémie | n2=en:increased circulating transitional b cells (cd19+cd38+igm+) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased effector cd8+ t cells n1=dysgammaglobulinémie | n2=en:increased effector cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased frequency of bacterial, viral, and fungal infections n1=dysgammaglobulinémie | n2=en:increased frequency of bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased ig n1=dysgammaglobulinémie | n2=en:increased ig | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased iga level n1=dysgammaglobulinémie | n2=en:increased iga level | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased ige impaired nk cell activity n1=dysgammaglobulinémie | n2=en:increased ige impaired nk cell activity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased ige level n1=dysgammaglobulinémie | n2=en:increased ige level | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased igm (1 patient) n1=dysgammaglobulinémie | n2=en:increased igm (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased igm level n1=dysgammaglobulinémie | n2=en:increased igm level | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased il6, episodic n1=dysgammaglobulinémie | n2=en:increased il6, episodic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased levels of t cells bearing gamma/delta antigen receptor n1=dysgammaglobulinémie | n2=en:increased levels of t cells bearing gamma/delta antigen receptor | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors n1=dysgammaglobulinémie | n2=en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells n1=dysgammaglobulinémie | n2=en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased number of circulating lymphocytes n1=dysgammaglobulinémie | n2=en:increased number of circulating lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased number of peripheral cd3+ t cells n1=dysgammaglobulinémie | n2=en:increased number of peripheral cd3+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased percentage of naive b cells n1=dysgammaglobulinémie | n2=en:increased percentage of naive b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased percentage of naive igd+ igm+ cd27- b cells n1=dysgammaglobulinémie | n2=en:increased percentage of naive igd+ igm+ cd27- b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased percentage of naive t cells n1=dysgammaglobulinémie | n2=en:increased percentage of naive t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased proportion of cd19+ b cells n1=dysgammaglobulinémie | n2=en:increased proportion of cd19+ b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased proportion of hla dr+ and cd57+ t cells n1=dysgammaglobulinémie | n2=en:increased proportion of hla dr+ and cd57+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased serum ige n1=dysgammaglobulinémie | n2=en:increased serum ige | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased serum ige (1 patient) n1=dysgammaglobulinémie | n2=en:increased serum ige (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased serum ige, iga, igg n1=dysgammaglobulinémie | n2=en:increased serum ige, iga, igg | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased serum igm (in some patients) n1=dysgammaglobulinémie | n2=en:increased serum igm (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to bacterial infections n1=dysgammaglobulinémie | n2=en:increased susceptibility to bacterial infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to haemophilus influenzae infections n1=dysgammaglobulinémie | n2=en:increased susceptibility to haemophilus influenzae infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to infections n1=dysgammaglobulinémie | n2=en:increased susceptibility to infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to infections (bacterial, fungal, and viral) n1=dysgammaglobulinémie | n2=en:increased susceptibility to infections (bacterial, fungal, and viral) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to mycobacteria, bacteria, fungi, and viruses n1=dysgammaglobulinémie | n2=en:increased susceptibility to mycobacteria, bacteria, fungi, and viruses | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to neisseria infections n1=dysgammaglobulinémie | n2=en:increased susceptibility to neisseria infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to pneumocystis and cytomegalovirus infections n1=dysgammaglobulinémie | n2=en:increased susceptibility to pneumocystis and cytomegalovirus infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to severe and frequent infections with staphylococcus aureus n1=dysgammaglobulinémie | n2=en:increased susceptibility to severe and frequent infections with staphylococcus aureus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased susceptibility to streptococcus pneumoniae infections n1=dysgammaglobulinémie | n2=en:increased susceptibility to streptococcus pneumoniae infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased t cell activation n1=dysgammaglobulinémie | n2=en:increased t cell activation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased total number of cd19+ b cells n1=dysgammaglobulinémie | n2=en:increased total number of cd19+ b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:increased transitional b cells n1=dysgammaglobulinémie | n2=en:increased transitional b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:infectious disease immunology n1=dysgammaglobulinémie | n2=en:infectious disease immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:infectious mononucleosis n1=dysgammaglobulinémie | n2=en:infectious mononucleosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:intrinsic b cell defect n1=dysgammaglobulinémie | n2=en:intrinsic b cell defect | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:isolated absence of cd8+ t cells n1=dysgammaglobulinémie | n2=en:isolated absence of cd8+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:itk deficiency n1=dysgammaglobulinémie | n2=en:itk deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:kappa-chain deficiency n1=dysgammaglobulinémie | n2=en:kappa-chain deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lack of acquired antibodies n1=dysgammaglobulinémie | n2=en:lack of acquired antibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lack of cd27 expression on lymphocytes n1=dysgammaglobulinémie | n2=en:lack of cd27 expression on lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lack of circulating dendritic cells n1=dysgammaglobulinémie | n2=en:lack of circulating dendritic cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lack of circulating monocytes n1=dysgammaglobulinémie | n2=en:lack of circulating monocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lack of peripheral cd3+ t cells n1=dysgammaglobulinémie | n2=en:lack of peripheral cd3+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lack of thymus on ultrasound n1=dysgammaglobulinémie | n2=en:lack of thymus on ultrasound | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:leukocyte-adhesion deficiency syndrome n1=dysgammaglobulinémie | n2=en:leukocyte-adhesion deficiency syndrome | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:leukocytosis n1=dysgammaglobulinémie | n2=en:leukocytosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:leukopenia n1=dysgammaglobulinémie | n2=en:leukopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lipoprotein disorder n1=dysgammaglobulinémie | n2=en:lipoprotein disorder | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:loss of or marked reduction of v(d)j recombination activity n1=dysgammaglobulinémie | n2=en:loss of or marked reduction of v(d)j recombination activity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low igg n1=dysgammaglobulinémie | n2=en:low igg | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low igg and iga n1=dysgammaglobulinémie | n2=en:low igg and iga | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low igg in adolescence (2 of 4 affected individuals) n1=dysgammaglobulinémie | n2=en:low igg in adolescence (2 of 4 affected individuals) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low igg with antibody deficiency n1=dysgammaglobulinémie | n2=en:low igg with antibody deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low levels of antibodies to s. pneumoniae, h. influenzae type b n1=dysgammaglobulinémie | n2=en:low levels of antibodies to s. pneumoniae, h. influenzae type b | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low levels of memory b cells n1=dysgammaglobulinémie | n2=en:low levels of memory b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low memory b cells n1=dysgammaglobulinémie | n2=en:low memory b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low naive t cells n1=dysgammaglobulinémie | n2=en:low naive t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low nk cells n1=dysgammaglobulinémie | n2=en:low nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low or normal serum immunoglobulins n1=dysgammaglobulinémie | n2=en:low or normal serum immunoglobulins | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) n1=dysgammaglobulinémie | n2=en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low t-cell function n1=dysgammaglobulinémie | n2=en:low t-cell function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low to normal immunoglobulin levels n1=dysgammaglobulinémie | n2=en:low to normal immunoglobulin levels | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low-absent igg, iga n1=dysgammaglobulinémie | n2=en:low-absent igg, iga | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low-normal iga levels n1=dysgammaglobulinémie | n2=en:low-normal iga levels | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:low-to-absent igg, iga, ige n1=dysgammaglobulinémie | n2=en:low-to-absent igg, iga, ige | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lupus-like syndrome (in some patients) n1=dysgammaglobulinémie | n2=en:lupus-like syndrome (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils n1=dysgammaglobulinémie | n2=en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymph node hyperplasia n1=dysgammaglobulinémie | n2=en:lymph node hyperplasia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymph nodes are small and poorly developed n1=dysgammaglobulinémie | n2=en:lymph nodes are small and poorly developed | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells n1=dysgammaglobulinémie | n2=en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas n1=dysgammaglobulinémie | n2=en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphadenitis n1=dysgammaglobulinémie | n2=en:lymphadenitis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphadenitis subsequent to bcg vaccination (in 1 patient) n1=dysgammaglobulinémie | n2=en:lymphadenitis subsequent to bcg vaccination (in 1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphadenopathy (cervical, inguinal, axillary) n1=dysgammaglobulinémie | n2=en:lymphadenopathy (cervical, inguinal, axillary) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphadenopathy in late phase n1=dysgammaglobulinémie | n2=en:lymphadenopathy in late phase | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphadenopathy may occur n1=dysgammaglobulinémie | n2=en:lymphadenopathy may occur | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphadenopathy subsequent to bcg vaccination n1=dysgammaglobulinémie | n2=en:lymphadenopathy subsequent to bcg vaccination | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphocyte count normal n1=dysgammaglobulinémie | n2=en:lymphocyte count normal | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphocyte function antigen-1 defect n1=dysgammaglobulinémie | n2=en:lymphocyte function antigen-1 defect | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs n1=dysgammaglobulinémie | n2=en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphohistiocytosis n1=dysgammaglobulinémie | n2=en:lymphohistiocytosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphoid depletion n1=dysgammaglobulinémie | n2=en:lymphoid depletion | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphoid hyperplasia n1=dysgammaglobulinémie | n2=en:lymphoid hyperplasia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphoid hypoplasia n1=dysgammaglobulinémie | n2=en:lymphoid hypoplasia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphopenia n1=dysgammaglobulinémie | n2=en:lymphopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphopenia, progressive n1=dysgammaglobulinémie | n2=en:lymphopenia, progressive | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:lymphoproliferation n1=dysgammaglobulinémie | n2=en:lymphoproliferation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:marked depletion of lymphoid tissues n1=dysgammaglobulinémie | n2=en:marked depletion of lymphoid tissues | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:marked reduction in cd4+/cd8+ ratio (in some patients) n1=dysgammaglobulinémie | n2=en:marked reduction in cd4+/cd8+ ratio (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:markedly depressed t lymphocyte proportion n1=dysgammaglobulinémie | n2=en:markedly depressed t lymphocyte proportion | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:markedly elevated ige levels n1=dysgammaglobulinémie | n2=en:markedly elevated ige levels | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:markedly reduced cd3+ proportion n1=dysgammaglobulinémie | n2=en:markedly reduced cd3+ proportion | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:markedly reduced neutrophil motility n1=dysgammaglobulinémie | n2=en:markedly reduced neutrophil motility | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:markedly reduced numbers of natural killer cells n1=dysgammaglobulinémie | n2=en:markedly reduced numbers of natural killer cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:markedly reduced t cell function n1=dysgammaglobulinémie | n2=en:markedly reduced t cell function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy n1=dysgammaglobulinémie | n2=en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:metabolic aspects n1=dysgammaglobulinémie | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:microbiological n1=dysgammaglobulinémie | n2=en:microbiological | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:microorganism immunology n1=dysgammaglobulinémie | n2=en:microorganism immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:mild to moderately reduced t cell count n1=dysgammaglobulinémie | n2=en:mild to moderately reduced t cell count | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:mildly decreased or normal t-cell proliferative responses n1=dysgammaglobulinémie | n2=en:mildly decreased or normal t-cell proliferative responses | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:mildly decreased proliferative responses of t cells n1=dysgammaglobulinémie | n2=en:mildly decreased proliferative responses of t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:moderate-low complement c3 n1=dysgammaglobulinémie | n2=en:moderate-low complement c3 | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:moderately depressed antibody response to polysaccharide antigens n1=dysgammaglobulinémie | n2=en:moderately depressed antibody response to polysaccharide antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:moderately elevated ige n1=dysgammaglobulinémie | n2=en:moderately elevated ige | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:monocytes show impaired motility n1=dysgammaglobulinémie | n2=en:monocytes show impaired motility | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:monocytopenia n1=dysgammaglobulinémie | n2=en:monocytopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:monocytosis n1=dysgammaglobulinémie | n2=en:monocytosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:mycobacterial infection n1=dysgammaglobulinémie | n2=en:mycobacterial infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:myeloid proliferation n1=dysgammaglobulinémie | n2=en:myeloid proliferation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:natural killer cell and glucocorticoid deficiency with dna repair defect n1=dysgammaglobulinémie | n2=en:natural killer cell and glucocorticoid deficiency with dna repair defect | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:natural killer cells, reduced numbers and cytotoxicity n1=dysgammaglobulinémie | n2=en:natural killer cells, reduced numbers and cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:natural killer t cell count decreased n1=dysgammaglobulinémie | n2=en:natural killer t cell count decreased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:neonatal sepsis n1=dysgammaglobulinémie | n2=en:neonatal sepsis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:neoplasm/cancer immunology n1=dysgammaglobulinémie | n2=en:neoplasm/cancer immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:neuroimmunology n1=dysgammaglobulinémie | n2=en:neuroimmunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:neuroimmunomodulation n1=dysgammaglobulinémie | n2=en:neuroimmunomodulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:neutropenia n1=dysgammaglobulinémie | n2=en:neutropenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:neutropenia (in some patients) n1=dysgammaglobulinémie | n2=en:neutropenia (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:nijmegen breakage syndrome n1=dysgammaglobulinémie | n2=en:nijmegen breakage syndrome | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:nk cells showed unusual surface cd16 antibody reactions n1=dysgammaglobulinémie | n2=en:nk cells showed unusual surface cd16 antibody reactions | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no antibodies to intrinsic factor n1=dysgammaglobulinémie | n2=en:no antibodies to intrinsic factor | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no concurrent allergies n1=dysgammaglobulinémie | n2=en:no concurrent allergies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no concurrent parasitic infection n1=dysgammaglobulinémie | n2=en:no concurrent parasitic infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no evidence of common prenatal infections n1=dysgammaglobulinémie | n2=en:no evidence of common prenatal infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no evidence of immunodeficiency n1=dysgammaglobulinémie | n2=en:no evidence of immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no evidence of intrauterine or perinatal infection n1=dysgammaglobulinémie | n2=en:no evidence of intrauterine or perinatal infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no evidence of prenatal infection n1=dysgammaglobulinémie | n2=en:no evidence of prenatal infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no immune defects reported n1=dysgammaglobulinémie | n2=en:no immune defects reported | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no immunodeficiency n1=dysgammaglobulinémie | n2=en:no immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no immunologic abnormalities n1=dysgammaglobulinémie | n2=en:no immunologic abnormalities | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no response to pneumococcal vaccination n1=dysgammaglobulinémie | n2=en:no response to pneumococcal vaccination | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:no severe viral infections n1=dysgammaglobulinémie | n2=en:no severe viral infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:non-caseating granulomas (bone marrow and lymph nodes) n1=dysgammaglobulinémie | n2=en:non-caseating granulomas (bone marrow and lymph nodes) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system n1=dysgammaglobulinémie | n2=en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal activity of natural killer cells n1=dysgammaglobulinémie | n2=en:normal activity of natural killer cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal b cells n1=dysgammaglobulinémie | n2=en:normal b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal b-cell (cd19+) count n1=dysgammaglobulinémie | n2=en:normal b-cell (cd19+) count | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal b-cell count n1=dysgammaglobulinémie | n2=en:normal b-cell count | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal igg, iga, igm, ige levels n1=dysgammaglobulinémie | n2=en:normal igg, iga, igm, ige levels | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal levels of igm, iga, and igg n1=dysgammaglobulinémie | n2=en:normal levels of igm, iga, and igg | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal nk cells n1=dysgammaglobulinémie | n2=en:normal nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal number of b cells n1=dysgammaglobulinémie | n2=en:normal number of b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal number of circulating lymphocytes n1=dysgammaglobulinémie | n2=en:normal number of circulating lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal number of natural killer cells n1=dysgammaglobulinémie | n2=en:normal number of natural killer cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal number of t cells n1=dysgammaglobulinémie | n2=en:normal number of t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of absolute b cells n1=dysgammaglobulinémie | n2=en:normal numbers of absolute b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of b cells n1=dysgammaglobulinémie | n2=en:normal numbers of b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of cd19+ b-lymphocytes n1=dysgammaglobulinémie | n2=en:normal numbers of cd19+ b-lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of circulating t cells n1=dysgammaglobulinémie | n2=en:normal numbers of circulating t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of lymphocytes n1=dysgammaglobulinémie | n2=en:normal numbers of lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of lymphocytes and nk cells n1=dysgammaglobulinémie | n2=en:normal numbers of lymphocytes and nk cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal numbers of t and b cells n1=dysgammaglobulinémie | n2=en:normal numbers of t and b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal or elevated lymphocytes n1=dysgammaglobulinémie | n2=en:normal or elevated lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal or elevated number of peripheral blood b cells n1=dysgammaglobulinémie | n2=en:normal or elevated number of peripheral blood b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal or elevated numbers of functional natural killer cells (nk) n1=dysgammaglobulinémie | n2=en:normal or elevated numbers of functional natural killer cells (nk) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal or increased numbers of b cells n1=dysgammaglobulinémie | n2=en:normal or increased numbers of b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal or reduced numbers of b cells n1=dysgammaglobulinémie | n2=en:normal or reduced numbers of b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal response to bacterial antigens n1=dysgammaglobulinémie | n2=en:normal response to bacterial antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal serum immunoglobulin levels n1=dysgammaglobulinémie | n2=en:normal serum immunoglobulin levels | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal t cells n1=dysgammaglobulinémie | n2=en:normal t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal t-cell numbers n1=dysgammaglobulinémie | n2=en:normal t-cell numbers | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal titers to t cell-dependent vaccines n1=dysgammaglobulinémie | n2=en:normal titers to t cell-dependent vaccines | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal to elevated igg n1=dysgammaglobulinémie | n2=en:normal to elevated igg | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:normal-elevated igm n1=dysgammaglobulinémie | n2=en:normal-elevated igm | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:nursing therapy n1=dysgammaglobulinémie | n2=en:nursing therapy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:nut hypersensitivity n1=dysgammaglobulinémie | n2=en:nut hypersensitivity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:often an infecting organism cannot be identified n1=dysgammaglobulinémie | n2=en:often an infecting organism cannot be identified | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:opportunistic infection n1=dysgammaglobulinémie | n2=en:opportunistic infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:opportunistic infections (cmv, pneumocystis, candida) n1=dysgammaglobulinémie | n2=en:opportunistic infections (cmv, pneumocystis, candida) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:opportunistic infections include nocardia asteroides and mycobacterium avium complex n1=dysgammaglobulinémie | n2=en:opportunistic infections include nocardia asteroides and mycobacterium avium complex | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:osteomyelitis due to immunodeficiency n1=dysgammaglobulinémie | n2=en:osteomyelitis due to immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha n1=dysgammaglobulinémie | n2=en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:panhypogammaglobulinemia n1=dysgammaglobulinémie | n2=en:panhypogammaglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:papillomavirus infections n1=dysgammaglobulinémie | n2=en:papillomavirus infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:paraproteinemia n1=dysgammaglobulinémie | n2=en:paraproteinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:parasitology n1=dysgammaglobulinémie | n2=en:parasitology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:partial humoral immunodeficiency n1=dysgammaglobulinémie | n2=en:partial humoral immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:partial t-cell lymphopenia n1=dysgammaglobulinémie | n2=en:partial t-cell lymphopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:partially defective antibody production n1=dysgammaglobulinémie | n2=en:partially defective antibody production | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:pathological aspects n1=dysgammaglobulinémie | n2=en:pathological aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:paucity of lymphoid tissue n1=dysgammaglobulinémie | n2=en:paucity of lymphoid tissue | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:perforin deficiency n1=dysgammaglobulinémie | n2=en:perforin deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:peripheral lymphopenia n1=dysgammaglobulinémie | n2=en:peripheral lymphopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:perirectal abscess n1=dysgammaglobulinémie | n2=en:perirectal abscess | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:pgm3 deficiency n1=dysgammaglobulinémie | n2=en:pgm3 deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:phagocyte bactericidal dysfunction n1=dysgammaglobulinémie | n2=en:phagocyte bactericidal dysfunction | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:phagocytic immunodeficiency n1=dysgammaglobulinémie | n2=en:phagocytic immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:physiopathological n1=dysgammaglobulinémie | n2=en:physiopathological | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:polyclonal b-cell lymphocytosis n1=dysgammaglobulinémie | n2=en:polyclonal b-cell lymphocytosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:polymorphic b cell lymphoproliferation n1=dysgammaglobulinémie | n2=en:polymorphic b cell lymphoproliferation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:polymorphonuclear leukocytosis, episodic n1=dysgammaglobulinémie | n2=en:polymorphonuclear leukocytosis, episodic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity n1=dysgammaglobulinémie | n2=en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:poor antibody response n1=dysgammaglobulinémie | n2=en:poor antibody response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:poor differentiation and proliferation of b and t cells n1=dysgammaglobulinémie | n2=en:poor differentiation and proliferation of b and t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation n1=dysgammaglobulinémie | n2=en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:poor proliferative response of t lymphocytes to specific antigens n1=dysgammaglobulinémie | n2=en:poor proliferative response of t lymphocytes to specific antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:poor t-cell mitogen response n1=dysgammaglobulinémie | n2=en:poor t-cell mitogen response | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:positive anti-nucleus antibodies n1=dysgammaglobulinémie | n2=en:positive anti-nucleus antibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:positive antinuclear autoantibodies n1=dysgammaglobulinémie | n2=en:positive antinuclear autoantibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:post-vaccination varicella (in 1 patient) n1=dysgammaglobulinémie | n2=en:post-vaccination varicella (in 1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) n1=dysgammaglobulinémie | n2=en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:pregnancy immunology n1=dysgammaglobulinémie | n2=en:pregnancy immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:presence of c3 nephritic factor autoantibody n1=dysgammaglobulinémie | n2=en:presence of c3 nephritic factor autoantibody | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:present but small tonsils n1=dysgammaglobulinémie | n2=en:present but small tonsils | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:primary immune deficiency disorder n1=dysgammaglobulinémie | n2=en:primary immune deficiency disorder | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:properdin deficiency, x-linked n1=dysgammaglobulinémie | n2=en:properdin deficiency, x-linked | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:protein c deficiency disease n1=dysgammaglobulinémie | n2=en:protein c deficiency disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:protein s deficiency disease n1=dysgammaglobulinémie | n2=en:protein s deficiency disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:pseudomonas infections n1=dysgammaglobulinémie | n2=en:pseudomonas infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:psychology qualifier n1=dysgammaglobulinémie | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:qualitative abnormality of granulocyte n1=dysgammaglobulinémie | n2=en:qualitative abnormality of granulocyte | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:radiotherapeutic n1=dysgammaglobulinémie | n2=en:radiotherapeutic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent bacterial infection n1=dysgammaglobulinémie | n2=en:recurrent bacterial infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent bacterial skin infections n1=dysgammaglobulinémie | n2=en:recurrent bacterial skin infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent bacterial, viral, and fungal infections n1=dysgammaglobulinémie | n2=en:recurrent bacterial, viral, and fungal infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent candida infections n1=dysgammaglobulinémie | n2=en:recurrent candida infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent candidal infections n1=dysgammaglobulinémie | n2=en:recurrent candidal infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent cutaneous and systemic pyogenic infections n1=dysgammaglobulinémie | n2=en:recurrent cutaneous and systemic pyogenic infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent febrile illnesses n1=dysgammaglobulinémie | n2=en:recurrent febrile illnesses | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent fevers n1=dysgammaglobulinémie | n2=en:recurrent fevers | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent fungal infections n1=dysgammaglobulinémie | n2=en:recurrent fungal infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections (1 patient) n1=dysgammaglobulinémie | n2=en:recurrent infections (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections (in severe cases) n1=dysgammaglobulinémie | n2=en:recurrent infections (in severe cases) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections (in some patients) n1=dysgammaglobulinémie | n2=en:recurrent infections (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) n1=dysgammaglobulinémie | n2=en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections (pneumonia, sinusitis, fulminant varicella) n1=dysgammaglobulinémie | n2=en:recurrent infections (pneumonia, sinusitis, fulminant varicella) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) n1=dysgammaglobulinémie | n2=en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections due to ciliary dysfunction n1=dysgammaglobulinémie | n2=en:recurrent infections due to ciliary dysfunction | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections in infancy and early childhood n1=dysgammaglobulinémie | n2=en:recurrent infections in infancy and early childhood | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections of mucosal surfaces n1=dysgammaglobulinémie | n2=en:recurrent infections of mucosal surfaces | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections, bacterial and fungal n1=dysgammaglobulinémie | n2=en:recurrent infections, bacterial and fungal | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections, bacterial, viral, fungal, myobacterial n1=dysgammaglobulinémie | n2=en:recurrent infections, bacterial, viral, fungal, myobacterial | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections, particularly herpes viral n1=dysgammaglobulinémie | n2=en:recurrent infections, particularly herpes viral | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent infections, particularly to viruses and fungi n1=dysgammaglobulinémie | n2=en:recurrent infections, particularly to viruses and fungi | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent meningococcal disease n1=dysgammaglobulinémie | n2=en:recurrent meningococcal disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent mycobacterial disease (bcg and m. tuberculosis) n1=dysgammaglobulinémie | n2=en:recurrent mycobacterial disease (bcg and m. tuberculosis) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent neisserial infections n1=dysgammaglobulinémie | n2=en:recurrent neisserial infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent opportunistic infections n1=dysgammaglobulinémie | n2=en:recurrent opportunistic infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent respiratory infections n1=dysgammaglobulinémie | n2=en:recurrent respiratory infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent severe and invasive bacterial infections n1=dysgammaglobulinémie | n2=en:recurrent severe and invasive bacterial infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent sinopulmonary infections n1=dysgammaglobulinémie | n2=en:recurrent sinopulmonary infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent skin and respiratory infections n1=dysgammaglobulinémie | n2=en:recurrent skin and respiratory infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent staphylococcal and gram-negative infections n1=dysgammaglobulinémie | n2=en:recurrent staphylococcal and gram-negative infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent staphylococcus aureus infections n1=dysgammaglobulinémie | n2=en:recurrent staphylococcus aureus infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent upper respiratory tract infection n1=dysgammaglobulinémie | n2=en:recurrent upper respiratory tract infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:recurrent viral infections n1=dysgammaglobulinémie | n2=en:recurrent viral infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced cd3 t-lymphocyte counts n1=dysgammaglobulinémie | n2=en:reduced cd3 t-lymphocyte counts | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced cd3+, cd4+, and cd8+ t-lymphocytes n1=dysgammaglobulinémie | n2=en:reduced cd3+, cd4+, and cd8+ t-lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced cd4 t-lymphocyte counts n1=dysgammaglobulinémie | n2=en:reduced cd4 t-lymphocyte counts | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced cd4+ t cells n1=dysgammaglobulinémie | n2=en:reduced cd4+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced cd4+/cd8+ ratio with cd8+ predominance n1=dysgammaglobulinémie | n2=en:reduced cd4+/cd8+ ratio with cd8+ predominance | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced delayed hypersensitivity n1=dysgammaglobulinémie | n2=en:reduced delayed hypersensitivity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced natural killer cell activity n1=dysgammaglobulinémie | n2=en:reduced natural killer cell activity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced natural killer cell cytotoxicity n1=dysgammaglobulinémie | n2=en:reduced natural killer cell cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced natural killer cell number n1=dysgammaglobulinémie | n2=en:reduced natural killer cell number | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced number of ct4+ t cells (in some patients) n1=dysgammaglobulinémie | n2=en:reduced number of ct4+ t cells (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced number of naive t cells (in some patients) n1=dysgammaglobulinémie | n2=en:reduced number of naive t cells (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced numbers of memory b cells n1=dysgammaglobulinémie | n2=en:reduced numbers of memory b cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes n1=dysgammaglobulinémie | n2=en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced t cell cytotoxicity n1=dysgammaglobulinémie | n2=en:reduced t cell cytotoxicity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:reduced/absent cd3+ t cells n1=dysgammaglobulinémie | n2=en:reduced/absent cd3+ t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:rehabilitation aspects n1=dysgammaglobulinémie | n2=en:rehabilitation aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:relative t-cell anergy n1=dysgammaglobulinémie | n2=en:relative t-cell anergy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:relatively increased number of natural killer cells n1=dysgammaglobulinémie | n2=en:relatively increased number of natural killer cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:repeated invasive infections n1=dysgammaglobulinémie | n2=en:repeated invasive infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:residual rag1 and rag2 activity n1=dysgammaglobulinémie | n2=en:residual rag1 and rag2 activity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:roentgenographic n1=dysgammaglobulinémie | n2=en:roentgenographic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:seasonal allergic rhinitis n1=dysgammaglobulinémie | n2=en:seasonal allergic rhinitis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:secondary immune deficiency disorder n1=dysgammaglobulinémie | n2=en:secondary immune deficiency disorder | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:secondary respiratory infections n1=dysgammaglobulinémie | n2=en:secondary respiratory infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:selective iga immunodeficiency n1=dysgammaglobulinémie | n2=en:selective iga immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:septicemia n1=dysgammaglobulinémie | n2=en:septicemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:serum autoantibodies n1=dysgammaglobulinémie | n2=en:serum autoantibodies | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:serum circulating immune complexes contain galactose-deficient iga1 n1=dysgammaglobulinémie | n2=en:serum circulating immune complexes contain galactose-deficient iga1 | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:serum complement decreased n1=dysgammaglobulinémie | n2=en:serum complement decreased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:serum iga, igg, and ige severely deficient n1=dysgammaglobulinémie | n2=en:serum iga, igg, and ige severely deficient | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) n1=dysgammaglobulinémie | n2=en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:serum immunoglobulins may be absent, normal, or increased n1=dysgammaglobulinémie | n2=en:serum immunoglobulins may be absent, normal, or increased | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severe b lymphocytopenia n1=dysgammaglobulinémie | n2=en:severe b lymphocytopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severe combined immunodeficiency n1=dysgammaglobulinémie | n2=en:severe combined immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severe enteroviral infections n1=dysgammaglobulinémie | n2=en:severe enteroviral infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severe viral infections n1=dysgammaglobulinémie | n2=en:severe viral infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severely reduced proliferative response to mitogens, antigens, and alloantigens n1=dysgammaglobulinémie | n2=en:severely reduced proliferative response to mitogens, antigens, and alloantigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severely reduced response to candida and tetanus toxoid antigens n1=dysgammaglobulinémie | n2=en:severely reduced response to candida and tetanus toxoid antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:severely reduced response to mitogens n1=dysgammaglobulinémie | n2=en:severely reduced response to mitogens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:sh2d1a deficiency n1=dysgammaglobulinémie | n2=en:sh2d1a deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:skin anergy to recall antigens n1=dysgammaglobulinémie | n2=en:skin anergy to recall antigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:slightly reduced neutrophil adherence n1=dysgammaglobulinémie | n2=en:slightly reduced neutrophil adherence | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:small lymph nodes n1=dysgammaglobulinémie | n2=en:small lymph nodes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:small lymph nodes, which lack paracortical regions n1=dysgammaglobulinémie | n2=en:small lymph nodes, which lack paracortical regions | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:small or absent thymus, which contains poorly formed hassal corpuscles n1=dysgammaglobulinémie | n2=en:small or absent thymus, which contains poorly formed hassal corpuscles | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency n1=dysgammaglobulinémie | n2=en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:specific antibody production very poor n1=dysgammaglobulinémie | n2=en:specific antibody production very poor | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:staphylococcus aureus infection n1=dysgammaglobulinémie | n2=en:staphylococcus aureus infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:surgical aspects n1=dysgammaglobulinémie | n2=en:surgical aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:susceptibility to bacterial infections due to poor skin integrity n1=dysgammaglobulinémie | n2=en:susceptibility to bacterial infections due to poor skin integrity | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:susceptibility to chickenpox n1=dysgammaglobulinémie | n2=en:susceptibility to chickenpox | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:susceptibility to infection by mycobacterium leprae causing leprosy n1=dysgammaglobulinémie | n2=en:susceptibility to infection by mycobacterium leprae causing leprosy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:susceptibility to infection with human herpesvirus n1=dysgammaglobulinémie | n2=en:susceptibility to infection with human herpesvirus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:susceptibility to infections n1=dysgammaglobulinémie | n2=en:susceptibility to infections | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:susceptibility to mycobacterial disease n1=dysgammaglobulinémie | n2=en:susceptibility to mycobacterial disease | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:swollen lymph node n1=dysgammaglobulinémie | n2=en:swollen lymph node | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:systemic inflammatory response (in some patients) n1=dysgammaglobulinémie | n2=en:systemic inflammatory response (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:systemic lupus erythematosus n1=dysgammaglobulinémie | n2=en:systemic lupus erythematosus | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t cell defect, mild to severe n1=dysgammaglobulinémie | n2=en:t cell defect, mild to severe | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t regulatory cells show poor function n1=dysgammaglobulinémie | n2=en:t regulatory cells show poor function | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-cell dysfunction (1 patient) n1=dysgammaglobulinémie | n2=en:t-cell dysfunction (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-cell dysfunction, variable (in some patients) n1=dysgammaglobulinémie | n2=en:t-cell dysfunction, variable (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-cell hyporesponsiveness (in some patients) n1=dysgammaglobulinémie | n2=en:t-cell hyporesponsiveness (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-cell immunodeficiency n1=dysgammaglobulinémie | n2=en:t-cell immunodeficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis n1=dysgammaglobulinémie | n2=en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-lymphocyte deficiency n1=dysgammaglobulinémie | n2=en:t-lymphocyte deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:t-lymphocytopenia n1=dysgammaglobulinémie | n2=en:t-lymphocytopenia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:taxonomic n1=dysgammaglobulinémie | n2=en:taxonomic | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:tert deficiency n1=dysgammaglobulinémie | n2=en:tert deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:therapeutic aspects n1=dysgammaglobulinémie | n2=en:therapeutic aspects | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:thymic hypoplasia or aplasia n1=dysgammaglobulinémie | n2=en:thymic hypoplasia or aplasia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:thymoma n1=dysgammaglobulinémie | n2=en:thymoma | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:thymus hypoplasia (in some patients) n1=dysgammaglobulinémie | n2=en:thymus hypoplasia (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:thyroid hormone deficiency (1 patient) n1=dysgammaglobulinémie | n2=en:thyroid hormone deficiency (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:tissue biopsy shows granulomas n1=dysgammaglobulinémie | n2=en:tissue biopsy shows granulomas | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:tnf continuously elevated (in some patients) n1=dysgammaglobulinémie | n2=en:tnf continuously elevated (in some patients) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:transient hypogammaglobulinemia of infancy n1=dysgammaglobulinémie | n2=en:transient hypogammaglobulinemia of infancy | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:transient iga deficiency (1 patient) n1=dysgammaglobulinémie | n2=en:transient iga deficiency (1 patient) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:transplantation immunology n1=dysgammaglobulinémie | n2=en:transplantation immunology | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:unc13d deficiency n1=dysgammaglobulinémie | n2=en:unc13d deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:undetectable igm and iga n1=dysgammaglobulinémie | n2=en:undetectable igm and iga | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:upregulation of alpha-interferon-stimulated genes n1=dysgammaglobulinémie | n2=en:upregulation of alpha-interferon-stimulated genes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:use of ultrasonography n1=dysgammaglobulinémie | n2=en:use of ultrasonography | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) n1=dysgammaglobulinémie | n2=en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:vacuolated lymphocytes n1=dysgammaglobulinémie | n2=en:vacuolated lymphocytes | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells n1=dysgammaglobulinémie | n2=en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:variable antibody response to vaccination n1=dysgammaglobulinémie | n2=en:variable antibody response to vaccination | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:variable autoimmune disorders n1=dysgammaglobulinémie | n2=en:variable autoimmune disorders | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:variable deficit of tissue macrophages n1=dysgammaglobulinémie | n2=en:variable deficit of tissue macrophages | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:variably decreased serum iga, igg, and igm n1=dysgammaglobulinémie | n2=en:variably decreased serum iga, igg, and igm | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:varicella zoster infection n1=dysgammaglobulinémie | n2=en:varicella zoster infection | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:very low lymphocyte proliferation in response to mitogens and alloantigens n1=dysgammaglobulinémie | n2=en:very low lymphocyte proliferation in response to mitogens and alloantigens | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:viruses n1=dysgammaglobulinémie | n2=en:viruses | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:vitiligo n1=dysgammaglobulinémie | n2=en:vitiligo | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:waldenstrom macroglobulinemia n1=dysgammaglobulinémie | n2=en:waldenstrom macroglobulinemia | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:x-linked lymphoproliferative syndrome n1=dysgammaglobulinémie | n2=en:x-linked lymphoproliferative syndrome | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 31 / 0.62 -> en:xiap deficiency n1=dysgammaglobulinémie | n2=en:xiap deficiency | rel=r_associated | relid=0 | w=31 dysgammaglobulinémie -- r_associated #0: 29 / 0.58 -> en:dysgammaglobulinemia n1=dysgammaglobulinémie | n2=en:dysgammaglobulinemia | rel=r_associated | relid=0 | w=29 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:abnormal immunoglobulin level n1=dysgammaglobulinémie | n2=en:abnormal immunoglobulin level | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:abnormality of humoral immunity n1=dysgammaglobulinémie | n2=en:abnormality of humoral immunity | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:absence of lymph nodes (in 1 patient) n1=dysgammaglobulinémie | n2=en:absence of lymph nodes (in 1 patient) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:allergy to eggs n1=dysgammaglobulinémie | n2=en:allergy to eggs | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:approximately 60% of patients have anti-gad65 antibodies n1=dysgammaglobulinémie | n2=en:approximately 60% of patients have anti-gad65 antibodies | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:arthritis n1=dysgammaglobulinémie | n2=en:arthritis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:ataxia telangiectasia syndrome n1=dysgammaglobulinémie | n2=en:ataxia telangiectasia syndrome | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:autoimmune neutropenia (less common) n1=dysgammaglobulinémie | n2=en:autoimmune neutropenia (less common) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:b-cell lymphopenia n1=dysgammaglobulinémie | n2=en:b-cell lymphopenia | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:chronic fatigue syndrome n1=dysgammaglobulinémie | n2=en:chronic fatigue syndrome | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:chronic noninfectious lymphadenopathy n1=dysgammaglobulinémie | n2=en:chronic noninfectious lymphadenopathy | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased cytotoxic t cell activity n1=dysgammaglobulinémie | n2=en:decreased cytotoxic t cell activity | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased igm and igg2 n1=dysgammaglobulinémie | n2=en:decreased igm and igg2 | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased immunoglobulins, progressive n1=dysgammaglobulinémie | n2=en:decreased immunoglobulins, progressive | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased memory t cells n1=dysgammaglobulinémie | n2=en:decreased memory t cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased natural killer cells n1=dysgammaglobulinémie | n2=en:decreased natural killer cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased natural killer t cells n1=dysgammaglobulinémie | n2=en:decreased natural killer t cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased number of cd4+ t cells n1=dysgammaglobulinémie | n2=en:decreased number of cd4+ t cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased numbers of circulating nk cells (less than 5%) n1=dysgammaglobulinémie | n2=en:decreased numbers of circulating nk cells (less than 5%) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:decreased serum igg and igm n1=dysgammaglobulinémie | n2=en:decreased serum igg and igm | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:defect in b-cell differentiation n1=dysgammaglobulinémie | n2=en:defect in b-cell differentiation | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:defective antigen-specific skin response n1=dysgammaglobulinémie | n2=en:defective antigen-specific skin response | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:defective b cell class-switching n1=dysgammaglobulinémie | n2=en:defective b cell class-switching | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:defective cd95-induced apoptosis of peripheral blood lymphocytes n1=dysgammaglobulinémie | n2=en:defective cd95-induced apoptosis of peripheral blood lymphocytes | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:defective neutrophil adhesion to endothelial cells n1=dysgammaglobulinémie | n2=en:defective neutrophil adhesion to endothelial cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:defective production of nfkb1-dependent cytokines by white blood cells n1=dysgammaglobulinémie | n2=en:defective production of nfkb1-dependent cytokines by white blood cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:deficiency of humoral immunity n1=dysgammaglobulinémie | n2=en:deficiency of humoral immunity | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:delayed wound healing with normal immune system n1=dysgammaglobulinémie | n2=en:delayed wound healing with normal immune system | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:dendritic cell cytopenia n1=dysgammaglobulinémie | n2=en:dendritic cell cytopenia | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:disseminated candidiasis n1=dysgammaglobulinémie | n2=en:disseminated candidiasis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) n1=dysgammaglobulinémie | n2=en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:embryologic n1=dysgammaglobulinémie | n2=en:embryologic | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:exaggerated cellular immune processes n1=dysgammaglobulinémie | n2=en:exaggerated cellular immune processes | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:fertility immunology n1=dysgammaglobulinémie | n2=en:fertility immunology | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:generalized lymphohistiocytic infiltrates in late phase n1=dysgammaglobulinémie | n2=en:generalized lymphohistiocytic infiltrates in late phase | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:granulomas, non-infectious n1=dysgammaglobulinémie | n2=en:granulomas, non-infectious | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation n1=dysgammaglobulinémie | n2=en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system n1=dysgammaglobulinémie | n2=en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:humoral defect (in some) n1=dysgammaglobulinémie | n2=en:humoral defect (in some) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hyperglobulinemia, polyclonal (in some patients) n1=dysgammaglobulinémie | n2=en:hyperglobulinemia, polyclonal (in some patients) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hyperimmunoglobulin m syndrome n1=dysgammaglobulinémie | n2=en:hyperimmunoglobulin m syndrome | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hyperinflammatory state n1=dysgammaglobulinémie | n2=en:hyperinflammatory state | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hypocomplementemia (in some patients) n1=dysgammaglobulinémie | n2=en:hypocomplementemia (in some patients) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:hypoglobulinemia n1=dysgammaglobulinémie | n2=en:hypoglobulinemia | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:immunodeficiency syndrome n1=dysgammaglobulinémie | n2=en:immunodeficiency syndrome | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:impaired immune responses n1=dysgammaglobulinémie | n2=en:impaired immune responses | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:impaired lymphocyte apoptosis n1=dysgammaglobulinémie | n2=en:impaired lymphocyte apoptosis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:increase in cd8+ t cells (in some patients) n1=dysgammaglobulinémie | n2=en:increase in cd8+ t cells (in some patients) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis n1=dysgammaglobulinémie | n2=en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:increased susceptibility to ebv infection n1=dysgammaglobulinémie | n2=en:increased susceptibility to ebv infection | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:klebsiella infections n1=dysgammaglobulinémie | n2=en:klebsiella infections | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:lack of autoantibodies n1=dysgammaglobulinémie | n2=en:lack of autoantibodies | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:lymphadenopathy (in some patients) n1=dysgammaglobulinémie | n2=en:lymphadenopathy (in some patients) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:lymphadenopathy, generalized (in some patients) n1=dysgammaglobulinémie | n2=en:lymphadenopathy, generalized (in some patients) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:lymphopenia (1 family) n1=dysgammaglobulinémie | n2=en:lymphopenia (1 family) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:magt1 deficiency n1=dysgammaglobulinémie | n2=en:magt1 deficiency | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:molecular immunology n1=dysgammaglobulinémie | n2=en:molecular immunology | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:neutrophils show defective intracellular nadph oxidase production n1=dysgammaglobulinémie | n2=en:neutrophils show defective intracellular nadph oxidase production | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis n1=dysgammaglobulinémie | n2=en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal b cell function n1=dysgammaglobulinémie | n2=en:normal b cell function | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal cell mediated immunity n1=dysgammaglobulinémie | n2=en:normal cell mediated immunity | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal lymphocyte response to pokeweed mitogen and conconavalin a n1=dysgammaglobulinémie | n2=en:normal lymphocyte response to pokeweed mitogen and conconavalin a | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal numbers and function of t cells n1=dysgammaglobulinémie | n2=en:normal numbers and function of t cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal numbers of cd56+ natural killer cells n1=dysgammaglobulinémie | n2=en:normal numbers of cd56+ natural killer cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal or decreased numbers of circulating b cells n1=dysgammaglobulinémie | n2=en:normal or decreased numbers of circulating b cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal or increased igm n1=dysgammaglobulinémie | n2=en:normal or increased igm | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal or increased numbers of transitional b cells n1=dysgammaglobulinémie | n2=en:normal or increased numbers of transitional b cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:normal thymus n1=dysgammaglobulinémie | n2=en:normal thymus | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:nutritional management n1=dysgammaglobulinémie | n2=en:nutritional management | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:pharmacotherapeutic n1=dysgammaglobulinémie | n2=en:pharmacotherapeutic | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:polysaccharide antibody response defect n1=dysgammaglobulinémie | n2=en:polysaccharide antibody response defect | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:primary combined immunodeficiency (1 patient) n1=dysgammaglobulinémie | n2=en:primary combined immunodeficiency (1 patient) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation n1=dysgammaglobulinémie | n2=en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:psychoneuroimmunology n1=dysgammaglobulinémie | n2=en:psychoneuroimmunology | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:recurrent bacterial and viral infections n1=dysgammaglobulinémie | n2=en:recurrent bacterial and viral infections | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:recurrent cutaneous mycoses n1=dysgammaglobulinémie | n2=en:recurrent cutaneous mycoses | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:recurrent infections n1=dysgammaglobulinémie | n2=en:recurrent infections | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:recurrent infections (pulmonary, skin, teeth) n1=dysgammaglobulinémie | n2=en:recurrent infections (pulmonary, skin, teeth) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:recurrent infections (sinusitis and bacterial pneumonia and meningitis) n1=dysgammaglobulinémie | n2=en:recurrent infections (sinusitis and bacterial pneumonia and meningitis) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:recurrent severe infections n1=dysgammaglobulinémie | n2=en:recurrent severe infections | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:reduced levels of cells with igm receptors n1=dysgammaglobulinémie | n2=en:reduced levels of cells with igm receptors | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:reduction of mature b cells n1=dysgammaglobulinémie | n2=en:reduction of mature b cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:sepsis n1=dysgammaglobulinémie | n2=en:sepsis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:serratia marcescens infection n1=dysgammaglobulinémie | n2=en:serratia marcescens infection | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:sjogren syndrome n1=dysgammaglobulinémie | n2=en:sjogren syndrome | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:stxbp2 deficiency n1=dysgammaglobulinémie | n2=en:stxbp2 deficiency | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:susceptible to vaccine-induced polio n1=dysgammaglobulinémie | n2=en:susceptible to vaccine-induced polio | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:systemic lupus erythematosis (in some patients) n1=dysgammaglobulinémie | n2=en:systemic lupus erythematosis (in some patients) | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:t cells may show impaired proliferative response to tetanus toxoid n1=dysgammaglobulinémie | n2=en:t cells may show impaired proliferative response to tetanus toxoid | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:terc deficiency n1=dysgammaglobulinémie | n2=en:terc deficiency | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:undetectable/absent peripheral lymph nodes n1=dysgammaglobulinémie | n2=en:undetectable/absent peripheral lymph nodes | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:variable degree of t cell dysfunction n1=dysgammaglobulinémie | n2=en:variable degree of t cell dysfunction | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:variably impaired t-cell proliferative responses n1=dysgammaglobulinémie | n2=en:variably impaired t-cell proliferative responses | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:vasculitis n1=dysgammaglobulinémie | n2=en:vasculitis | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:very low b cells n1=dysgammaglobulinémie | n2=en:very low b cells | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 26 / 0.52 -> en:veterinary aspects n1=dysgammaglobulinémie | n2=en:veterinary aspects | rel=r_associated | relid=0 | w=26 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> carence immunitaire n1=dysgammaglobulinémie | n2=carence immunitaire | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> déficience immunitaire n1=dysgammaglobulinémie | n2=déficience immunitaire | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> Déficit immunitaire n1=dysgammaglobulinémie | n2=Déficit immunitaire | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> en:dysglobulinaemia n1=dysgammaglobulinémie | n2=en:dysglobulinaemia | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> en:immune deficiency n1=dysgammaglobulinémie | n2=en:immune deficiency | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> en:immunizing deficit n1=dysgammaglobulinémie | n2=en:immunizing deficit | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> en:immunodeficiency n1=dysgammaglobulinémie | n2=en:immunodeficiency | rel=r_associated | relid=0 | w=20 dysgammaglobulinémie -- r_associated #0: 20 / 0.4 -> immunodéficience n1=dysgammaglobulinémie | n2=immunodéficience | rel=r_associated | relid=0 | w=20

≈ 900 relations entrantes dysgammaglobulinémies --- r_associated #0: 42 --> dysgammaglobulinémie n1=dysgammaglobulinémies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=42 Déficit immunitaire --- r_associated #0: 40 --> dysgammaglobulinémie n1=Déficit immunitaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=40 dysglobulinémie --- r_associated #0: 40 --> dysgammaglobulinémie n1=dysglobulinémie | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=40 déficit immunitaire --- r_associated #0: 40 --> dysgammaglobulinémie n1=déficit immunitaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=40 en:immune deficiency --- r_associated #0: 40 --> dysgammaglobulinémie n1=en:immune deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=40 en:immunizing deficit --- r_associated #0: 40 --> dysgammaglobulinémie n1=en:immunizing deficit | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=40 en:immunodeficiency --- r_associated #0: 39 --> dysgammaglobulinémie n1=en:immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=39 déficience immunitaire --- r_associated #0: 30 --> dysgammaglobulinémie n1=déficience immunitaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=30 en:dysgammaglobulinemia --- r_associated #0: 30 --> dysgammaglobulinémie n1=en:dysgammaglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=30 carence immunitaire --- r_associated #0: 29 --> dysgammaglobulinémie n1=carence immunitaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=29 en:dysglobulinaemia --- r_associated #0: 28 --> dysgammaglobulinémie n1=en:dysglobulinaemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=28 immunodéficience --- r_associated #0: 28 --> dysgammaglobulinémie n1=immunodéficience | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=28 infection généralisée --- r_associated #0: 25 --> dysgammaglobulinémie n1=infection généralisée | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=25 immunodéficience ou déficit immunitaire --- r_associated #0: 24 --> dysgammaglobulinémie n1=immunodéficience ou déficit immunitaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=24 processus pathologique --- r_associated #0: 24 --> dysgammaglobulinémie n1=processus pathologique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=24 immunodéficit --- r_associated #0: 21 --> dysgammaglobulinémie n1=immunodéficit | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=21 en:abnormal b cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormal b cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormal delayed hypersensitivity skin test --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormal delayed hypersensitivity skin test | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormal immunoglobulin level --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormal immunoglobulin level | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormal lymphocytic accumulation in non-lymphoid tissue --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormal lymphocytic accumulation in non-lymphoid tissue | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormal ratios of cd4+ helper t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormal ratios of cd4+ helper t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormality of b cell physiology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormality of b cell physiology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormality of humoral immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormality of humoral immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormality of t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormality of t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abnormally large monocytes with vacuoles --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abnormally large monocytes with vacuoles | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abscess formation in any organ --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abscess formation in any organ | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abscesses are 'cold,' lacking erythema, heat, and swelling --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abscesses are 'cold,' lacking erythema, heat, and swelling | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of acetylcholine receptor (achr) autoantibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of acetylcholine receptor (achr) autoantibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of anti-thyroid antibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of anti-thyroid antibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of auto-antibodies to intrinsic factor or parietal cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of auto-antibodies to intrinsic factor or parietal cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of bactericidal oxidative 'respiratory burst' in phagocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of bactericidal oxidative 'respiratory burst' in phagocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of cd3+ t cells (1 family) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of cd3+ t cells (1 family) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of humoral and cellular immune response to foreign antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of humoral and cellular immune response to foreign antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of lymph node germinal center --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of lymph node germinal center | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of lymph nodes (in 1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of lymph nodes (in 1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of pancreatic autoantibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of pancreatic autoantibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absence of pus formation at site of infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absence of pus formation at site of infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent antibody production --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent antibody production | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent b lymphocytes in all organs --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent b lymphocytes in all organs | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent cellular immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent cellular immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent delayed hypersensitivity skin test --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent delayed hypersensitivity skin test | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent humoral immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent humoral immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent microvilli on the surface of peripheral blood lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent microvilli on the surface of peripheral blood lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent mitogenic response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent mitogenic response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent mitogenic response to staphylococcus aureus cowan antigen (sac) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent natural killer cell cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent natural killer cell cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent or reduced cd3+ cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent or reduced cd3+ cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent or severely reduced numbers of b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent or severely reduced numbers of b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent or small dysplastic thymus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent or small dysplastic thymus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent peripheral blood b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent peripheral blood b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent peripheral blood t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent peripheral blood t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent plasma cells in all organs --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent plasma cells in all organs | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent sialyl-lewis x ligand (slex) expression --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent sialyl-lewis x ligand (slex) expression | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent specific antibody response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent specific antibody response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent t lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent t lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absent thymus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absent thymus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:absolute lymphocyte count decreased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:absolute lymphocyte count decreased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:abundant cd4+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:abundant cd4+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:acetylcholine receptor (achr) autoantibodies are found in a subset of patients | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:acquired immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:acquired immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:acquired immunodeficiency syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:acquired immunodeficiency syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:activated hla dr+ t cells in peripheral blood --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:activated hla dr+ t cells in peripheral blood | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:activated mononuclear phagocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:activated mononuclear phagocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:activated t-helper cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:activated t-helper cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:activation of the alternative complement pathway and depletion of complement components --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:activation of the alternative complement pathway and depletion of complement components | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:activation of the complement system --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:activation of the complement system | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:agammaglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:agammaglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:allergic to dogs --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:allergic to dogs | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:allergy to eggs --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:allergy to eggs | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:alpha/beta, cd4-/cd8- t cells are minimally or not increased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:alpha/beta, cd4-/cd8- t cells are minimally or not increased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:altered t-cell regulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:altered t-cell regulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:angioedema --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:angioedema | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antibody --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antibody | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antibody-dependent cellular cytotoxicity of nk cells is unaffected --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antibody-dependent cellular cytotoxicity of nk cells is unaffected | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antigen --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antigen | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antigenically defective c8 detected --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antigenically defective c8 detected | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antinuclear antibody present (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antinuclear antibody present (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antinuclear antibody present, speckled pattern --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antinuclear antibody present, speckled pattern | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antinuclear autoantibodies (in some) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antinuclear autoantibodies (in some) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:antithrombin iii deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:antithrombin iii deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:aplasia of thymus gland with immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:aplasia of thymus gland with immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:approximately 60% of patients have anti-gad65 antibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:approximately 60% of patients have anti-gad65 antibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:armed macrophage --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:armed macrophage | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:arrest of b cell development at very early stage --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:arrest of b cell development at very early stage | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:arthritis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:arthritis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:aspects of mortality statistics --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:aspects of mortality statistics | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:aspects of radionuclide imaging --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:aspects of radionuclide imaging | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:aspergillus infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:aspergillus infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:associated with autoantibodies to gad65 (anti-glutamic acid decarboxylase gad2, 138275) in serum and/or cerebrospinal fluid | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:associated with autoimmune disorders (e.g., diabetes mellitus, thyroiditis, pernicious anemia, vitiligo) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:associated with autoimmune disorders (systemic lupus erythematosus 152700 and hashimoto thyroiditis 140300) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:associated with serum autoantibodies to glra1 (glycine receptor alpha-1 subunit 138491, reported in 1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:association with autoimmune diseases --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:association with autoimmune diseases | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:asthma --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:asthma | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:ataxia telangiectasia syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:ataxia telangiectasia syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:atopic disorders (eczema, food allergy, asthma) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:atopic disorders (eczema, food allergy, asthma) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoantibodies (anti-nuclear, anti-dsdna, anti-cardiolipin) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoantibodies (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoantibodies (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoantibodies, transient --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoantibodies, transient | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoantibody --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoantibody | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune disease (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune disease (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune disease resembling systemic lupus erythematosis (sle, 152700) (in about 26%) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune disease resembling systemic lupus erythematosis (sle, 152700) (in about 26%) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune disorders (i.e., itp, juvenile rheumatoid arthritis (jra), hypothyroidism, crohn disease) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune disorders (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune disorders (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune features (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune features (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmune neutropenia (less common) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmune neutropenia (less common) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoimmunity to pancreatic beta cells (rare) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoimmunity to pancreatic beta cells (rare) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoinflammation, systemic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoinflammation, systemic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:autoinflammatory disorders --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:autoinflammatory disorders | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b and t cell defects (reported in 2 sibs) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b and t cell defects (reported in 2 sibs) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b cells lack surface cd19 and cd81 expression --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b cells lack surface cd19 and cd81 expression | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b cells lack surface cd19 expression --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b cells lack surface cd19 expression | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b cells lack surface cd20 expression --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b cells lack surface cd20 expression | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b-cell lymphocytosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b-cell lymphocytosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b-cell lymphopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b-cell lymphopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:b-lymphocyte immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:b-lymphocyte immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:biopsy shows lipid-laden macrophages --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:biopsy shows lipid-laden macrophages | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:block at the pro-b to pre-b stage of differentiation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:block at the pro-b to pre-b stage of differentiation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:block of b-cell differentiation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:block of b-cell differentiation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:blood protein disorders --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:blood protein disorders | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:bone marrow shows lymphoid hyperplasia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:bone marrow shows lymphoid hyperplasia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:burkholderia cepacia infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:burkholderia cepacia infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:c1q deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:c1q deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:c1q molecule present, but dysfunctional --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:c1q molecule present, but dysfunctional | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:c2 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:c2 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:c8 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:c8 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cancer immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cancer immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cd4+ t-cell lymphopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cd4+ t-cell lymphopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cd4/cd8 ratio decreased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cd4/cd8 ratio decreased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cd40 ligand deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cd40 ligand deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cells show impaired immunologic responses to immune stimulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cells show impaired immunologic responses to immune stimulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cellular immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cellular immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cellular immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cellular immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cellulitis due to immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cellulitis due to immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:chemically induced --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:chemically induced | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:childhood-onset systemic lupus erythematosus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:childhood-onset systemic lupus erythematosus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:chronic fatigue syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:chronic fatigue syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:chronic human papillomavirus (hpv) infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:chronic human papillomavirus (hpv) infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:chronic mucocutaneous candidiasis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:chronic mucocutaneous candidiasis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:chronic noninfectious lymphadenopathy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:chronic noninfectious lymphadenopathy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:chronic viral infections (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:chronic viral infections (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:circulating immune complexes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:circulating immune complexes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:circulating t and b cells are naive --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:circulating t and b cells are naive | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:clinical immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:clinical immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:combined humoral and cellular immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:combined humoral and cellular immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:combined immunodeficiency (reported in 1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:combined immunodeficiency (reported in 1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:combined variable immunodeficiency involving b and t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:combined variable immunodeficiency involving b and t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:common variable immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:common variable immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:complement component consumption --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:complement component consumption | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:complement deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:complement deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:complication aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:complication aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital agammaglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital agammaglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital blood protein disorder --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital blood protein disorder | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital combined immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital combined immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital disorder of natural immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital disorder of natural immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital hypoplasia of thymus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital hypoplasia of thymus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital immunodeficiency disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital immunodeficiency disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:congenital mesh qualifier --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:congenital mesh qualifier | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:continuous activation of the alternative complement pathway --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:continuous activation of the alternative complement pathway | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cow's milk protein sensitivity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cow's milk protein sensitivity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cutaneous anergy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cutaneous anergy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:cytokine defects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:cytokine defects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased b cell survival and tolerance --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased b cell survival and tolerance | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd19+ b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd19+ b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd27+ b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd27+ b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd3 complex --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd3 complex | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd3 expression on t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd3 expression on t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd3(-)cd16/15(+) natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd3(-)cd16/15(+) natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd3+ cells subset --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd3+ cells subset | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd4+ and cd3+/cd4+ lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd4+ and cd3+/cd4+ lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd4+ cells subset --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd4+ cells subset | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd4+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd4+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd4+cd45ra+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd4+cd45ra+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd8+ cells subset --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd8+ cells subset | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cellular caspase-8 levels --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cellular caspase-8 levels | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulating b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulating b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulating b cells (total cd19+) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulating b cells (total cd19+) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulating cd4+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulating cd4+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulating class-switched memory b cells (cd19+cd27+igd-) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulating naive t cells (1 family) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulating naive t cells (1 family) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulating nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulating nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased circulation t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased circulation t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cytotoxic activity of cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cytotoxic activity of cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased cytotoxic t cell activity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased cytotoxic t cell activity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased differentiated b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased differentiated b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased effector t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased effector t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased iga, plasma and secretory --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased iga, plasma and secretory | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased igm and igg2 --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased igm and igg2 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased immunoglobulin g (igg) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased immunoglobulin g (igg) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased immunoglobulins, progressive --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased immunoglobulins, progressive | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased invariant nk t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased invariant nk t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased itk protein in lymphoid tissue --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased itk protein in lymphoid tissue | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased levels of naive t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased levels of naive t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased lymphatic tissue (tonsil, thymus, mesenteric nodes, peyer patches) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased memory b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased memory b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased memory b cells (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased memory b cells (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased memory b cells, progressive --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased memory b cells, progressive | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased memory t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased memory t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased naive cd4+ and cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased naive cd4+ and cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased natural killer t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased natural killer t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased neutrophil and monocyte migration and chemotaxis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased neutrophil and monocyte migration and chemotaxis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased nk cells, particularly nk cell precursors --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased nk cells, particularly nk cell precursors | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased nk levels (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased nk levels (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased number of cd4+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased number of cd4+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased number of cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased number of cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased number of tcr alpha/beta+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased number of tcr alpha/beta+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of circulating nk cells (less than 5%) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of circulating nk cells (less than 5%) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of long-term memory cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of long-term memory cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of mature b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of mature b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of naive cd4+ and cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of naive cd4+ and cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of natural killer cells (nk) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of natural killer cells (nk) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased numbers of thymus emigrant cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased numbers of thymus emigrant cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased or absent pre-b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased or absent pre-b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased or normal numbers of nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased or normal numbers of nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased percentage of igd+ igm+ cd27+ memory b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased percentage of igd+ igm+ cd27+ memory b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased percentage of igd- igm- cd27+ class-switched memory b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased percentage of igd- igm- cd27+ class-switched memory b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased regulatory t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased regulatory t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum complement c3 --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum complement c3 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum complement c3 (120700) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum complement c3 (120700) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum complement factor b (cfb, 138470) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum complement factor b (cfb, 138470) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum complement factor h (cfh, 134370) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum complement factor h (cfh, 134370) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum complement factor i --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum complement factor i | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum iga --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum iga | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum igg and igm --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum igg and igm | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased serum igm --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased serum igm | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased specific antibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased specific antibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t cell activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t cell activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t cell production of cytokines --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t cell production of cytokines | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t cell proliferation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t cell proliferation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t cell response to mitogens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t cell response to mitogens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t cell-dependent antibody production --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t cell-dependent antibody production | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t-cell proliferative response to mitogens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t-cell proliferative response to mitogens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:decreased t-cell proliferative responses in vitro --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:decreased t-cell proliferative responses in vitro | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defect in b-cell differentiation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defect in b-cell differentiation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defect in v(d)j recombination process --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defect in v(d)j recombination process | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective antibody production --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective antibody production | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective antibody production against polysaccharide-based vaccines --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective antibody production against polysaccharide-based vaccines | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective antibody production, particularly t-cell-independent --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective antibody production, particularly t-cell-independent | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective antibody response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective antibody response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective antigen-specific skin response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective antigen-specific skin response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective b cell activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective b cell activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective b cell class-switching --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective b cell class-switching | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective b cell differentiation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective b cell differentiation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective cd8+ t cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective cd8+ t cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective cd95-induced apoptosis of peripheral blood lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective cd95-induced apoptosis of peripheral blood lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective complement regulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective complement regulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective generation of somatic hypermutations (shm) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective generation of somatic hypermutations (shm) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective humoral response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective humoral response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective il21r-related signaling --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective il21r-related signaling | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective intracellular signaling in lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective intracellular signaling in lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective lymphocyte apoptosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective lymphocyte apoptosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective macrophage function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective macrophage function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective natural killer cell (nk) activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective natural killer cell (nk) activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective neutrophil adhesion to endothelial cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective neutrophil adhesion to endothelial cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective neutrophil function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective neutrophil function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective nk function in spontaneous cellular cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective nk function in spontaneous cellular cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective production of nfkb1-dependent cytokines by white blood cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective production of nfkb1-dependent cytokines by white blood cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective response of b and t cells to activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective response of b and t cells to activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:defective t cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:defective t cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:deficiency of humoral immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:deficiency of humoral immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:deficient nk-cell mediated spontaneous and antibody-mediated cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:delayed wound healing with normal immune system --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:delayed wound healing with normal immune system | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:deltaretrovirus infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:deltaretrovirus infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dendritic cell cytopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dendritic cell cytopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:depleted cd4+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:depleted cd4+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:depletion of components of the alternative complement pathway --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:depletion of components of the alternative complement pathway | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dermatomyositis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dermatomyositis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dermatomyositis (in 1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dermatomyositis (in 1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dermatophytic lymphadenitis (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dermatophytic lymphadenitis (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:developmental arrest of b cells at the pre-b to pro-b cell transition stage --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:developmental arrest of b cells at the pre-b to pro-b cell transition stage | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:developmental immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:developmental immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:diagnosis aspect --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:diagnosis aspect | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:diminished proliferative response of t cells to allogenic cells, mitogens, and antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:disseminated candidiasis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:disseminated candidiasis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:disseminated infection with dimorphic fungi (coccidioides and histoplasma) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dysfunctional alternative complement pathway --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dysfunctional alternative complement pathway | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dysfunctional nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dysfunctional nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dysglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dysglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:dysplasia of thymus gland with immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:dysplasia of thymus gland with immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:ectopic thymus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:ectopic thymus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:elevated iga (equal to or greater than 2.6g/l) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:elevated iga (equal to or greater than 2.6g/l) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:elevated igd --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:elevated igd | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:elevated immunoglobulins, particularly ige --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:elevated immunoglobulins, particularly ige | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:elevated levels of serum ige --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:elevated levels of serum ige | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:elevated polyclonal igd (equal to or greater than 100 iu/ml) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:elevated polyclonal igd (equal to or greater than 100 iu/ml) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:embryologic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:embryologic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:enterovirus infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:enterovirus infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:environmental illness --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:environmental illness | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:enzymology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:enzymology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:epidemiologic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:epidemiologic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:epilepsy telangiectasia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:epilepsy telangiectasia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:erythrophagocytosis in late phase --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:erythrophagocytosis in late phase | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:escherichia coli infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:escherichia coli infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:ethnologic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:ethnologic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:etiology aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:etiology aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:evidence of ebv infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:evidence of ebv infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:exaggerated cellular immune processes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:exaggerated cellular immune processes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:exposure as collected domain --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:exposure as collected domain | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:extrahepatic reticuloendothelial system spared --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:extrahepatic reticuloendothelial system spared | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:fertility immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:fertility immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:few mature neutrophils in the bone marrow --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:few mature neutrophils in the bone marrow | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:food allergies (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:food allergies (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:food allergy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:food allergy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:foot infections leading to amputation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:foot infections leading to amputation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:foot ulcer --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:foot ulcer | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent bacterial, fungal and viral infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent bacterial, fungal and viral infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent bacterial, viral, and opportunistic infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent bacterial, viral, and opportunistic infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent bacterial, viral, protozoan, and fungal infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent bacterial, viral, protozoan, and fungal infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent fungal, viral, and opportunistic infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent fungal, viral, and opportunistic infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent illnesses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent illnesses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent infections in childhood --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent infections in childhood | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:frequent infections t-lymphocyte dysfunction, rare --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:frequent infections t-lymphocyte dysfunction, rare | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:fulminant infectious mononucleosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:fulminant infectious mononucleosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:fungal infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:fungal infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:gammopathy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:gammopathy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:gata2 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:gata2 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:generalized enlarged lymph nodes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:generalized enlarged lymph nodes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:generalized lymphohistiocytic infiltrates in late phase --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:generalized lymphohistiocytic infiltrates in late phase | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:genetic aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:genetic aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:giant germinal centers in lymph nodes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:giant germinal centers in lymph nodes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:granulocyte dysfunction (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:granulocyte dysfunction (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:granuloma formation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:granuloma formation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:granulomas can appear on skin, tongue, lungs, or other tissues --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:granulomas can appear on skin, tongue, lungs, or other tissues | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:granulomas, non-infectious --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:granulomas, non-infectious | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hashimoto thyroiditis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hashimoto thyroiditis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:heavy chain disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:heavy chain disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hemoglobinopathy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hemoglobinopathy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hemophagocytic syndrome (hs) characterized by acute onset of uncontrolled t-lymphocyte and macrophage activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hemophagocytosis (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hemophagocytosis (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hemophagocytosis in bone marrow and lymph nodes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hemophagocytosis in bone marrow and lymph nodes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hemophagocytosis in bone marrow, lymph nodes, spleen, liver, and central nervous system | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hepatic abscesses due to immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hepatic abscesses due to immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:herpes simplex virus infection, mucocutaneous --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:herpes simplex virus infection, mucocutaneous | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:herpesviridae infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:herpesviridae infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:histology shows large regions of necrosis in lymph nodes, thymus, bone marrow, and spleen | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:historical aspects qualifier --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:historical aspects qualifier | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hiv infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hiv infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hla antigens cw6, b13, b17 associated with psoriasis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hla antigens cw6, b13, b17 associated with psoriasis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:humoral defect (in some) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:humoral defect (in some) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:humoral deficiency (likely result of t-cell abnormalities) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:humoral deficiency (likely result of t-cell abnormalities) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyper iga (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyper iga (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyper-igm immunodeficiency syndrome, type 1 --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyper-igm immunodeficiency syndrome, type 1 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypereosinophilia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypereosinophilia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypergammaglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypergammaglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypergammaglobulinemia (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypergammaglobulinemia (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperglobulinemia, polyclonal (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperglobulinemia, polyclonal (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperimmunoglobulin m syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperimmunoglobulin m syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperinflammatory disorder --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperinflammatory disorder | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperinflammatory state --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperinflammatory state | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperinflammatory state (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperinflammatory state (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperplasia of tonsils --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperplasia of tonsils | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperproliferation of effector t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperproliferation of effector t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hyperproteinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hyperproteinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypersensitivity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypersensitivity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypocomplementemia (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypocomplementemia (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypogammaglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypogammaglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypogammaglobulinemia (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypogammaglobulinemia (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypogammaglobulinemia (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypogammaglobulinemia (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypogammaglobulinemia, profound --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypogammaglobulinemia, profound | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypoglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypoglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypoglobulinemia result --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypoglobulinemia result | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypoimmunoglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypoimmunoglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypomorphic rag1 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypomorphic rag1 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypoplastic thymus which often lacks hassal corpuscles --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypoplastic thymus which often lacks hassal corpuscles | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:hypoproteinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:hypoproteinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:ifn-gamma receptor 1 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:ifn-gamma receptor 1 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:ige deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:ige deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:igg deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:igg deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:igg, decreased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:igg, decreased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:igm deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:igm deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:igm immunodeficiency (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:igm immunodeficiency (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:il6 continuously elevated (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:il6 continuously elevated (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immune defect due to a t cell deficit --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immune defect due to a t cell deficit | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immune dysregulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immune dysregulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immune response process --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immune response process | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunocompromised --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunocompromised | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency disorders nec --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency disorders nec | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency of unknown origin --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency of unknown origin | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency with hyper-igm --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency with hyper-igm | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency with thymoma --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency with thymoma | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency, primarily affecting b cell line --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency, primarily affecting b cell line | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunodeficiency, severe combined (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunodeficiency, severe combined (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunogenetics --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunogenetics | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunoglobulin a decreased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunoglobulin a decreased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunoglobulin a deficiency (disorder) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunoglobulin a deficiency (disorder) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunoglobulin deficiency (iga, igg, igm) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunoglobulin deficiency (iga, igg, igm) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunohematology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunohematology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunologic evaluation unremarkable --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunologic evaluation unremarkable | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunology aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunology aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunology, other --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunology, other | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunophenotyping --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunophenotyping | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunoregulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunoregulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunosecretory disorder --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunosecretory disorder | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:immunotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:immunotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired b cell class-switching --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired b cell class-switching | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired b cell memory cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired b cell memory cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired b-cell differentiation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired b-cell differentiation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired cellular and humoral immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired cellular and humoral immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired ig class switch recombination --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired ig class switch recombination | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired immune responses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired immune responses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired lymphocyte apoptosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired lymphocyte apoptosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired lymphocyte proliferation response to malignancy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired lymphocyte proliferation response to malignancy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired seroconversion of immunoglobulins in response to vaccination --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired seroconversion of immunoglobulins in response to vaccination | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired signaling through the t-cell receptor --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired signaling through the t-cell receptor | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired survival of mature t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired survival of mature t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired t cell activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired t cell activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired t cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired t cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired t cell immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired t cell immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired t cell proliferation and activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired t cell proliferation and activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired t cell proliferative response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired t cell proliferative response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:impaired t-cell proliferation to certain stimuli --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:impaired t-cell proliferation to certain stimuli | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:in blood --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:in blood | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:in cerebrospinal fluid --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:in cerebrospinal fluid | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:in urine --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:in urine | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:inability to mount antibody response to antigen --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:inability to mount antibody response to antigen | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:inability to reject allogenic cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:inability to reject allogenic cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:inborn immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:inborn immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increase in b cell number --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increase in b cell number | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increase in b cells (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increase in b cells (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increase in cd8+ t cells (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increase in cd8+ t cells (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increase in certain cytokines (il4, il5, il13, il17) upon stimulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased activated cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased activated cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased alpha-interferon activity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased alpha-interferon activity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased cd21+ (low) b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased cd21+ (low) b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased circulating transitional b cells (cd19+cd38+igm+) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased circulating transitional b cells (cd19+cd38+igm+) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased effector cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased effector cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased frequency of bacterial, viral, and fungal infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased frequency of bacterial, viral, and fungal infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased ig --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased ig | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased iga level --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased iga level | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased ige impaired nk cell activity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased ige impaired nk cell activity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased ige level --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased ige level | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased igm (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased igm (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased igm level --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased igm level | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased il6, episodic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased il6, episodic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased levels of t cells bearing gamma/delta antigen receptor --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased levels of t cells bearing gamma/delta antigen receptor | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased number of cd4(-)cd8(-)tcr-alpha-beta(+) t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased number of cd4-/cd8- t cells expressing alpha/beta t-cell receptors | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased number of circulating lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased number of circulating lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased number of peripheral cd3+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased number of peripheral cd3+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased percentage of naive b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased percentage of naive b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased percentage of naive igd+ igm+ cd27- b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased percentage of naive igd+ igm+ cd27- b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased percentage of naive t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased percentage of naive t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased proportion of cd19+ b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased proportion of cd19+ b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased proportion of hla dr+ and cd57+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased proportion of hla dr+ and cd57+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased serum ige --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased serum ige | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased serum ige (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased serum ige (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased serum ige, iga, igg --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased serum ige, iga, igg | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased serum igm (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased serum igm (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to bacterial infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to bacterial infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to certain bacterial infections, especially neisseria meningitidis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to ebv infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to ebv infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to haemophilus influenzae infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to haemophilus influenzae infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to infections (bacterial, fungal, and viral) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to infections (bacterial, fungal, and viral) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to mycobacteria, bacteria, fungi, and viruses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to mycobacteria, bacteria, fungi, and viruses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to neisseria infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to neisseria infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to pneumocystis and cytomegalovirus infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to pneumocystis and cytomegalovirus infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to severe and frequent infections with staphylococcus aureus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to severe and frequent infections with staphylococcus aureus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased susceptibility to streptococcus pneumoniae infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased susceptibility to streptococcus pneumoniae infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased t cell activation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased t cell activation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased total number of cd19+ b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased total number of cd19+ b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:increased transitional b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:increased transitional b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:infectious disease immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:infectious disease immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:infectious mononucleosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:infectious mononucleosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:intrinsic b cell defect --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:intrinsic b cell defect | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:isolated absence of cd8+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:isolated absence of cd8+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:itk deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:itk deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:kappa-chain deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:kappa-chain deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:klebsiella infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:klebsiella infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of acquired antibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of acquired antibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of autoantibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of autoantibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of cd27 expression on lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of cd27 expression on lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of circulating dendritic cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of circulating dendritic cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of circulating monocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of circulating monocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of peripheral cd3+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of peripheral cd3+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lack of thymus on ultrasound --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lack of thymus on ultrasound | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:leukocyte-adhesion deficiency syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:leukocyte-adhesion deficiency syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:leukocytosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:leukocytosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:leukopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:leukopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lipoprotein disorder --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lipoprotein disorder | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:loss of or marked reduction of v(d)j recombination activity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:loss of or marked reduction of v(d)j recombination activity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low igg --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low igg | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low igg and iga --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low igg and iga | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low igg in adolescence (2 of 4 affected individuals) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low igg in adolescence (2 of 4 affected individuals) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low igg with antibody deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low igg with antibody deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low levels of antibodies to s. pneumoniae, h. influenzae type b --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low levels of antibodies to s. pneumoniae, h. influenzae type b | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low levels of memory b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low levels of memory b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low memory b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low memory b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low naive t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low naive t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low or normal serum immunoglobulins --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low or normal serum immunoglobulins | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low specific antibody titers (e.g., tetanus, polio virus, mumps, rubella) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low t-cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low t-cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low to normal immunoglobulin levels --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low to normal immunoglobulin levels | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low-absent igg, iga --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low-absent igg, iga | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low-normal iga levels --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low-normal iga levels | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:low-to-absent igg, iga, ige --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:low-to-absent igg, iga, ige | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lupus-like syndrome (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lupus-like syndrome (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymph node architecture severely altered: lack of follicles, depletion of lymphocytes, and increased proportion of interdigitating reticular cells and eosinophils | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymph node hyperplasia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymph node hyperplasia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymph nodes are small and poorly developed --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymph nodes are small and poorly developed | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymph nodes show florid reactive follicular hyperplasia and marked paracortical expansion with immunoblasts and plasma cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymph nodes show reactive follicular hyperplasia and non-caseating granulomas | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenitis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenitis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenitis subsequent to bcg vaccination (in 1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenitis subsequent to bcg vaccination (in 1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenopathy (cervical, inguinal, axillary) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenopathy (cervical, inguinal, axillary) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenopathy (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenopathy (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenopathy in late phase --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenopathy in late phase | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenopathy may occur --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenopathy may occur | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenopathy subsequent to bcg vaccination --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenopathy subsequent to bcg vaccination | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphadenopathy, generalized (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphadenopathy, generalized (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphocyte count normal --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphocyte count normal | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphocyte function antigen-1 defect --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphocyte function antigen-1 defect | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphohistiocytic infiltration and hemophagocytosis in multiple organs | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphohistiocytosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphohistiocytosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphoid depletion --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphoid depletion | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphoid hyperplasia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphoid hyperplasia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphoid hypoplasia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphoid hypoplasia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphopenia (1 family) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphopenia (1 family) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphopenia, progressive --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphopenia, progressive | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:lymphoproliferation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:lymphoproliferation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:magt1 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:magt1 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:marked depletion of lymphoid tissues --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:marked depletion of lymphoid tissues | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:marked reduction in cd4+/cd8+ ratio (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:marked reduction in cd4+/cd8+ ratio (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:markedly depressed t lymphocyte proportion --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:markedly depressed t lymphocyte proportion | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:markedly elevated ige levels --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:markedly elevated ige levels | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:markedly reduced cd3+ proportion --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:markedly reduced cd3+ proportion | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:markedly reduced neutrophil motility --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:markedly reduced neutrophil motility | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:markedly reduced numbers of natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:markedly reduced numbers of natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:markedly reduced t cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:markedly reduced t cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:maturational arrest of granulocytes at the promyelocyte/myelocyte stage seen on bone marrow biopsy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:metabolic aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:metabolic aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:microbiological --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:microbiological | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:microorganism immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:microorganism immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:mild to moderately reduced t cell count --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:mild to moderately reduced t cell count | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:mildly decreased or normal t-cell proliferative responses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:mildly decreased or normal t-cell proliferative responses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:mildly decreased proliferative responses of t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:mildly decreased proliferative responses of t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:moderate-low complement c3 --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:moderate-low complement c3 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:moderately depressed antibody response to polysaccharide antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:moderately depressed antibody response to polysaccharide antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:moderately elevated ige --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:moderately elevated ige | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:molecular immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:molecular immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:monocytes show impaired motility --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:monocytes show impaired motility | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:monocytopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:monocytopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:monocytosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:monocytosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:mycobacterial infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:mycobacterial infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:myeloid proliferation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:myeloid proliferation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:natural killer cell and glucocorticoid deficiency with dna repair defect --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:natural killer cell and glucocorticoid deficiency with dna repair defect | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:natural killer cells, reduced numbers and cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:natural killer cells, reduced numbers and cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:natural killer t cell count decreased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:natural killer t cell count decreased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neonatal sepsis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neonatal sepsis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neoplasm/cancer immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neoplasm/cancer immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neuroimmunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neuroimmunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neuroimmunomodulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neuroimmunomodulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neutropenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neutropenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neutropenia (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neutropenia (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neutrophils show defective intracellular nadph oxidase production --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neutrophils show defective intracellular nadph oxidase production | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:neutrophils show disorganized lysosomal compartments on ultrastructural analysis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:nijmegen breakage syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:nijmegen breakage syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:nk cells showed unusual surface cd16 antibody reactions --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:nk cells showed unusual surface cd16 antibody reactions | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no antibodies to intrinsic factor --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no antibodies to intrinsic factor | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no concurrent allergies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no concurrent allergies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no concurrent parasitic infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no concurrent parasitic infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no evidence of common prenatal infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no evidence of common prenatal infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no evidence of immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no evidence of immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no evidence of intrauterine or perinatal infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no evidence of intrauterine or perinatal infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no evidence of prenatal infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no evidence of prenatal infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no immune defects reported --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no immune defects reported | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no immunologic abnormalities --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no immunologic abnormalities | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no response to pneumococcal vaccination --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no response to pneumococcal vaccination | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:no severe viral infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:no severe viral infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:non-caseating granulomas (bone marrow and lymph nodes) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:non-caseating granulomas (bone marrow and lymph nodes) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:non-malignant mixed lymphohistiocytic infiltration of the reticuloendothelial system | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal activity of natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal activity of natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal b cell function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal b cell function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal b-cell (cd19+) count --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal b-cell (cd19+) count | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal b-cell count --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal b-cell count | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal cell mediated immunity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal cell mediated immunity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal igg, iga, igm, ige levels --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal igg, iga, igm, ige levels | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal levels of igm, iga, and igg --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal levels of igm, iga, and igg | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal lymphocyte response to pokeweed mitogen and conconavalin a --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal lymphocyte response to pokeweed mitogen and conconavalin a | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal number of b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal number of b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal number of circulating lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal number of circulating lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal number of natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal number of natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal number of t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal number of t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers and function of t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers and function of t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of absolute b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of absolute b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of cd19+ b-lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of cd19+ b-lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of cd56+ natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of cd56+ natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of circulating t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of circulating t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of lymphocytes and nk cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of lymphocytes and nk cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal numbers of t and b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal numbers of t and b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or decreased numbers of circulating b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or decreased numbers of circulating b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or elevated lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or elevated lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or elevated number of peripheral blood b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or elevated number of peripheral blood b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or elevated numbers of functional natural killer cells (nk) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or elevated numbers of functional natural killer cells (nk) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or increased igm --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or increased igm | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or increased numbers of b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or increased numbers of b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or increased numbers of transitional b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or increased numbers of transitional b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal or reduced numbers of b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal or reduced numbers of b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal response to bacterial antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal response to bacterial antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal serum immunoglobulin levels --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal serum immunoglobulin levels | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal t-cell numbers --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal t-cell numbers | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal thymus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal thymus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal titers to t cell-dependent vaccines --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal titers to t cell-dependent vaccines | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal to elevated igg --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal to elevated igg | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:normal-elevated igm --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:normal-elevated igm | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:nursing therapy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:nursing therapy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:nut hypersensitivity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:nut hypersensitivity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:nutritional management --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:nutritional management | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:often an infecting organism cannot be identified --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:often an infecting organism cannot be identified | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:opportunistic infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:opportunistic infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:opportunistic infections (cmv, pneumocystis, candida) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:opportunistic infections (cmv, pneumocystis, candida) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:opportunistic infections include nocardia asteroides and mycobacterium avium complex --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:opportunistic infections include nocardia asteroides and mycobacterium avium complex | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:osteomyelitis due to immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:osteomyelitis due to immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:overproduction by t lymphocytes and macrophages of cytokines, particularly interferon gamma and tumor necrosis factor alpha | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:panhypogammaglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:panhypogammaglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:papillomavirus infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:papillomavirus infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:paraproteinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:paraproteinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:parasitology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:parasitology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:partial humoral immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:partial humoral immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:partial t-cell lymphopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:partial t-cell lymphopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:partially defective antibody production --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:partially defective antibody production | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:pathological aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:pathological aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:paucity of lymphoid tissue --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:paucity of lymphoid tissue | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:perforin deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:perforin deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:peripheral lymphopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:peripheral lymphopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:perirectal abscess --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:perirectal abscess | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:pgm3 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:pgm3 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:phagocyte bactericidal dysfunction --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:phagocyte bactericidal dysfunction | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:phagocytic immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:phagocytic immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:pharmacotherapeutic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:pharmacotherapeutic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:physiopathological --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:physiopathological | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:polyclonal b-cell lymphocytosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:polyclonal b-cell lymphocytosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:polymorphic b cell lymphoproliferation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:polymorphic b cell lymphoproliferation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:polymorphonuclear leukocytosis, episodic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:polymorphonuclear leukocytosis, episodic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:polysaccharide antibody response defect --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:polysaccharide antibody response defect | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:poor adhesion related functions, such as adhesion to endothelial cells, chemotaxis, and antibody-dependent cellular cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:poor antibody response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:poor antibody response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:poor differentiation and proliferation of b and t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:poor differentiation and proliferation of b and t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:poor production of certain cytokines (il-12, gamma-interferon, il-10, il-6, tnf-alpha) after stimulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:poor proliferative response of t lymphocytes to specific antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:poor proliferative response of t lymphocytes to specific antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:poor t-cell mitogen response --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:poor t-cell mitogen response | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:positive anti-nucleus antibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:positive anti-nucleus antibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:positive antinuclear autoantibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:positive antinuclear autoantibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:post-vaccination varicella (in 1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:post-vaccination varicella (in 1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:precipitated by infection (influenza a, influenza b, mycoplasma, hhv6) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:pregnancy immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:pregnancy immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:presence of c3 nephritic factor autoantibody --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:presence of c3 nephritic factor autoantibody | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:present but small tonsils --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:present but small tonsils | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:primary combined immunodeficiency (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:primary combined immunodeficiency (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:primary dysfunction of b-lymphocyte isotype switching and memory b-cell generation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:primary immune deficiency disorder --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:primary immune deficiency disorder | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:properdin deficiency, x-linked --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:properdin deficiency, x-linked | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:protein c deficiency disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:protein c deficiency disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:protein s deficiency disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:protein s deficiency disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:pseudomonas infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:pseudomonas infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:psychology qualifier --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:psychology qualifier | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:psychoneuroimmunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:psychoneuroimmunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:qualitative abnormality of granulocyte --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:qualitative abnormality of granulocyte | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:radiotherapeutic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:radiotherapeutic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent bacterial and viral infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent bacterial and viral infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent bacterial infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent bacterial infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent bacterial skin infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent bacterial skin infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent bacterial, viral, and fungal infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent bacterial, viral, and fungal infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent candida infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent candida infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent candidal infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent candidal infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent cutaneous and systemic pyogenic infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent cutaneous and systemic pyogenic infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent cutaneous mycoses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent cutaneous mycoses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent febrile illnesses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent febrile illnesses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent fevers --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent fevers | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent fungal infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent fungal infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (in severe cases) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (in severe cases) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (increased susceptibility to mycobacterial infection after bcg immunization) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (pneumonia, sinusitis, fulminant varicella) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (pneumonia, sinusitis, fulminant varicella) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (pulmonary, skin, teeth) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (pulmonary, skin, teeth) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections (sinusitis and bacterial pneumonia and meningitis) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections (sinusitis and bacterial pneumonia and meningitis) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections at variable sites (sinusitis, otitis media, facial cellulitis, adenitis, blepharitis, conjunctivitis, gastroenteritis) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections due to ciliary dysfunction --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections due to ciliary dysfunction | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections in infancy and early childhood --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections in infancy and early childhood | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections of mucosal surfaces --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections of mucosal surfaces | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections, bacterial and fungal --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections, bacterial and fungal | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections, bacterial, viral, fungal, myobacterial --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections, bacterial, viral, fungal, myobacterial | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections, particularly herpes viral --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections, particularly herpes viral | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent infections, particularly to viruses and fungi --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent infections, particularly to viruses and fungi | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent meningococcal disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent meningococcal disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent mycobacterial disease (bcg and m. tuberculosis) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent mycobacterial disease (bcg and m. tuberculosis) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent neisserial infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent neisserial infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent opportunistic infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent opportunistic infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent respiratory infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent respiratory infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent severe and invasive bacterial infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent severe and invasive bacterial infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent severe infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent severe infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent sinopulmonary infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent sinopulmonary infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent skin and respiratory infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent skin and respiratory infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent staphylococcal and gram-negative infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent staphylococcal and gram-negative infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent staphylococcus aureus infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent staphylococcus aureus infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent upper respiratory tract infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent upper respiratory tract infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:recurrent viral infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:recurrent viral infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced cd3 t-lymphocyte counts --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced cd3 t-lymphocyte counts | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced cd3+, cd4+, and cd8+ t-lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced cd3+, cd4+, and cd8+ t-lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced cd4 t-lymphocyte counts --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced cd4 t-lymphocyte counts | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced cd4+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced cd4+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced cd4+/cd8+ ratio with cd8+ predominance --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced cd4+/cd8+ ratio with cd8+ predominance | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced delayed hypersensitivity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced delayed hypersensitivity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced levels of cells with igm receptors --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced levels of cells with igm receptors | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced natural killer cell activity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced natural killer cell activity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced natural killer cell cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced natural killer cell cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced natural killer cell number --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced natural killer cell number | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced number of ct4+ t cells (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced number of ct4+ t cells (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced number of naive t cells (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced number of naive t cells (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced numbers of memory b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced numbers of memory b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced production of interleukin 2 by mitogen stimulated blood lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced t cell cytotoxicity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced t cell cytotoxicity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduced/absent cd3+ t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduced/absent cd3+ t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:reduction of mature b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:reduction of mature b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:rehabilitation aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:rehabilitation aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:relative t-cell anergy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:relative t-cell anergy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:relatively increased number of natural killer cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:relatively increased number of natural killer cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:repeated invasive infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:repeated invasive infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:residual rag1 and rag2 activity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:residual rag1 and rag2 activity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:roentgenographic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:roentgenographic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:seasonal allergic rhinitis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:seasonal allergic rhinitis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:secondary immune deficiency disorder --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:secondary immune deficiency disorder | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:secondary respiratory infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:secondary respiratory infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:selective iga immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:selective iga immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:sepsis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:sepsis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:septicemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:septicemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serratia marcescens infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serratia marcescens infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serum autoantibodies --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serum autoantibodies | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serum circulating immune complexes contain galactose-deficient iga1 --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serum circulating immune complexes contain galactose-deficient iga1 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serum complement decreased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serum complement decreased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serum iga, igg, and ige severely deficient --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serum iga, igg, and ige severely deficient | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serum igg autoantibodies to granulocyte/macrophage colony-stimulating factor (gm-csf, csf2, 138960) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:serum immunoglobulins may be absent, normal, or increased --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:serum immunoglobulins may be absent, normal, or increased | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severe b lymphocytopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severe b lymphocytopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severe combined immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severe combined immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severe enteroviral infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severe enteroviral infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severe viral infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severe viral infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severely reduced proliferative response to mitogens, antigens, and alloantigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severely reduced proliferative response to mitogens, antigens, and alloantigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severely reduced response to candida and tetanus toxoid antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severely reduced response to candida and tetanus toxoid antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:severely reduced response to mitogens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:severely reduced response to mitogens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:sh2d1a deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:sh2d1a deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:sjogren syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:sjogren syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:skin anergy to recall antigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:skin anergy to recall antigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:slightly reduced neutrophil adherence --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:slightly reduced neutrophil adherence | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:small lymph nodes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:small lymph nodes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:small lymph nodes, which lack paracortical regions --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:small lymph nodes, which lack paracortical regions | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:small or absent thymus, which contains poorly formed hassal corpuscles --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:small or absent thymus, which contains poorly formed hassal corpuscles | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:some patients may have autoantibodies to factor h, resulting in functional factor h deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:specific antibody production very poor --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:specific antibody production very poor | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:staphylococcus aureus infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:staphylococcus aureus infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:stxbp2 deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:stxbp2 deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:surgical aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:surgical aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptibility to bacterial infections due to poor skin integrity --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptibility to bacterial infections due to poor skin integrity | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptibility to chickenpox --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptibility to chickenpox | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptibility to infection by mycobacterium leprae causing leprosy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptibility to infection by mycobacterium leprae causing leprosy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptibility to infection with human herpesvirus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptibility to infection with human herpesvirus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptibility to infections --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptibility to infections | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptibility to mycobacterial disease --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptibility to mycobacterial disease | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:susceptible to vaccine-induced polio --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:susceptible to vaccine-induced polio | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:swollen lymph node --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:swollen lymph node | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:systemic inflammatory response (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:systemic inflammatory response (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:systemic lupus erythematosis (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:systemic lupus erythematosis (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:systemic lupus erythematosus --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:systemic lupus erythematosus | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t cell defect, mild to severe --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t cell defect, mild to severe | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t cells may show impaired proliferative response to tetanus toxoid --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t cells may show impaired proliferative response to tetanus toxoid | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t regulatory cells show poor function --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t regulatory cells show poor function | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-cell dysfunction (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-cell dysfunction (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-cell dysfunction, variable (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-cell dysfunction, variable (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-cell hyporesponsiveness (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-cell hyporesponsiveness (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-cell immunodeficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-cell immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-cells show reduced cytotoxicity and reduced cytolytic granule exocytosis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-lymphocyte deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-lymphocyte deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:t-lymphocytopenia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:t-lymphocytopenia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:taxonomic --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:taxonomic | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:terc deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:terc deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:tert deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:tert deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:therapeutic aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:therapeutic aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:thymic hypoplasia or aplasia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:thymic hypoplasia or aplasia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:thymoma --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:thymoma | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:thymus hypoplasia (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:thymus hypoplasia (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:thyroid hormone deficiency (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:thyroid hormone deficiency (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:tissue biopsy shows granulomas --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:tissue biopsy shows granulomas | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:tnf continuously elevated (in some patients) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:tnf continuously elevated (in some patients) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:transient hypogammaglobulinemia of infancy --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:transient hypogammaglobulinemia of infancy | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:transient iga deficiency (1 patient) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:transient iga deficiency (1 patient) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:transplantation immunology --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:transplantation immunology | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:unc13d deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:unc13d deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:undetectable igm and iga --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:undetectable igm and iga | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:undetectable/absent peripheral lymph nodes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:undetectable/absent peripheral lymph nodes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:upregulation of alpha-interferon-stimulated genes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:upregulation of alpha-interferon-stimulated genes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:use of ultrasonography --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:use of ultrasonography | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:usually precipitated by viral infection (influenza a, influenza b, parainfluenza ii, and mycoplasma pneumoniae) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:vacuolated lymphocytes --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:vacuolated lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variable (often increased) number of activated cd45ro+, dr+ circulating t cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variable antibody response to vaccination --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variable antibody response to vaccination | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variable autoimmune disorders --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variable autoimmune disorders | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variable deficit of tissue macrophages --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variable deficit of tissue macrophages | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variable degree of t cell dysfunction --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variable degree of t cell dysfunction | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variably decreased serum iga, igg, and igm --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variably decreased serum iga, igg, and igm | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:variably impaired t-cell proliferative responses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:variably impaired t-cell proliferative responses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:varicella zoster infection --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:varicella zoster infection | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:vasculitis --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:vasculitis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:very low b cells --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:very low b cells | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:very low lymphocyte proliferation in response to mitogens and alloantigens --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:very low lymphocyte proliferation in response to mitogens and alloantigens | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:veterinary aspects --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:veterinary aspects | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:viruses --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:viruses | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:vitiligo --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:vitiligo | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:waldenstrom macroglobulinemia --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:waldenstrom macroglobulinemia | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:x-linked lymphoproliferative syndrome --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:x-linked lymphoproliferative syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 en:xiap deficiency --- r_associated #0: 20 --> dysgammaglobulinémie n1=en:xiap deficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 neuro-immunomodulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=neuro-immunomodulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 neuroimmunomodulation --- r_associated #0: 20 --> dysgammaglobulinémie n1=neuroimmunomodulation | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 sepsis --- r_associated #0: 20 --> dysgammaglobulinémie n1=sepsis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=20 DFPD --- r_associated #0: 15 --> dysgammaglobulinémie n1=DFPD | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=15 Déficience immunitaire --- r_associated #0: 15 --> dysgammaglobulinémie n1=Déficience immunitaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=15 absence de production d'anticorps --- r_associated #0: 15 --> dysgammaglobulinémie n1=absence de production d'anticorps | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=15 absence de réponse spécifique d'anticorps --- r_associated #0: 15 --> dysgammaglobulinémie n1=absence de réponse spécifique d'anticorps | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=15 déficit homozygote de Fas (CD95) --- r_associated #0: 15 --> dysgammaglobulinémie n1=déficit homozygote de Fas (CD95) | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=15 Dysglobulinémie --- r_associated #0: 10 --> dysgammaglobulinémie n1=Dysglobulinémie | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 antigen --- r_associated #0: 10 --> dysgammaglobulinémie n1=antigen | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 asthme --- r_associated #0: 10 --> dysgammaglobulinémie n1=asthme | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 cytotoxicité absente des cellules tueuses naturelles --- r_associated #0: 10 --> dysgammaglobulinémie n1=cytotoxicité absente des cellules tueuses naturelles | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 déficience immunitaire commune variable --- r_associated #0: 10 --> dysgammaglobulinémie n1=déficience immunitaire commune variable | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 déficience immunitaire commune variable 5 --- r_associated #0: 10 --> dysgammaglobulinémie n1=déficience immunitaire commune variable 5 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 déficit f?tal en iode --- r_associated #0: 10 --> dysgammaglobulinémie n1=déficit f?tal en iode | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 en:iImmunodeficiency --- r_associated #0: 10 --> dysgammaglobulinémie n1=en:iImmunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 hémoglobinopathie --- r_associated #0: 10 --> dysgammaglobulinémie n1=hémoglobinopathie | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 immunodeficiency --- r_associated #0: 10 --> dysgammaglobulinémie n1=immunodeficiency | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 immunodépression --- r_associated #0: 10 --> dysgammaglobulinémie n1=immunodépression | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 infection systémique --- r_associated #0: 10 --> dysgammaglobulinémie n1=infection systémique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 infection à mycobactéries --- r_associated #0: 10 --> dysgammaglobulinémie n1=infection à mycobactéries | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 lupus érythémateux aigu disséminé --- r_associated #0: 10 --> dysgammaglobulinémie n1=lupus érythémateux aigu disséminé | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 paraprotéinémie --- r_associated #0: 10 --> dysgammaglobulinémie n1=paraprotéinémie | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 thymome --- r_associated #0: 10 --> dysgammaglobulinémie n1=thymome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 vascularite --- r_associated #0: 10 --> dysgammaglobulinémie n1=vascularite | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 vasculitis --- r_associated #0: 10 --> dysgammaglobulinémie n1=vasculitis | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 vitiligo --- r_associated #0: 10 --> dysgammaglobulinémie n1=vitiligo | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=10 absence d'expression de CD27 sur les lymphocytes --- r_associated #0: 5 --> dysgammaglobulinémie n1=absence d'expression de CD27 sur les lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 absence de cellules B dans le sang périphérique --- r_associated #0: 5 --> dysgammaglobulinémie n1=absence de cellules B dans le sang périphérique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 absence de cellules T dans le sang périphérique --- r_associated #0: 5 --> dysgammaglobulinémie n1=absence de cellules T dans le sang périphérique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 absence de lymphocytes B dans tous les organes --- r_associated #0: 5 --> dysgammaglobulinémie n1=absence de lymphocytes B dans tous les organes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 absence de lymphocytes T --- r_associated #0: 5 --> dysgammaglobulinémie n1=absence de lymphocytes T | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 absence de microvillosités à la surface des lymphocytes du sang périphérique --- r_associated #0: 5 --> dysgammaglobulinémie n1=absence de microvillosités à la surface des lymphocytes du sang périphérique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 anticorps --- r_associated #0: 5 --> dysgammaglobulinémie n1=anticorps | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 apoptose altérée des lymphocytes --- r_associated #0: 5 --> dysgammaglobulinémie n1=apoptose altérée des lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 apoptose défectueuse des lymphocytes --- r_associated #0: 5 --> dysgammaglobulinémie n1=apoptose défectueuse des lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 apoptose défectueuse induite par CD95 des lymphocytes du sang périphérique --- r_associated #0: 5 --> dysgammaglobulinémie n1=apoptose défectueuse induite par CD95 des lymphocytes du sang périphérique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 arthrite --- r_associated #0: 5 --> dysgammaglobulinémie n1=arthrite | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 augmentation du nombre de lymphocytes circulants --- r_associated #0: 5 --> dysgammaglobulinémie n1=augmentation du nombre de lymphocytes circulants | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 cellules T HLA DR+ activées dans le sang périphérique --- r_associated #0: 5 --> dysgammaglobulinémie n1=cellules T HLA DR+ activées dans le sang périphérique | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 diminution de la numération lymphocytaire absolue --- r_associated #0: 5 --> dysgammaglobulinémie n1=diminution de la numération lymphocytaire absolue | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 dysfonctionnement primaire de la commutation isotypique des lymphocytes B et de la génération de cellules B mémoires --- r_associated #0: 5 --> dysgammaglobulinémie n1=dysfonctionnement primaire de la commutation isotypique des lymphocytes B et de la génération de cellules B mémoires | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 défaut de l'antigène-1 de fonction lymphocytaire --- r_associated #0: 5 --> dysgammaglobulinémie n1=défaut de l'antigène-1 de fonction lymphocytaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 déficience en lymphocytes T --- r_associated #0: 5 --> dysgammaglobulinémie n1=déficience en lymphocytes T | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 déficit fonctionnel personnel temporaire --- r_associated #0: 5 --> dysgammaglobulinémie n1=déficit fonctionnel personnel temporaire | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 déficit idiopathique en lymphocytes T CD4+ --- r_associated #0: 5 --> dysgammaglobulinémie n1=déficit idiopathique en lymphocytes T CD4+ | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 en:Nijmegen breakage syndrome --- r_associated #0: 5 --> dysgammaglobulinémie n1=en:Nijmegen breakage syndrome | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 faible réponse proliférative des lymphocytes T aux antigènes spécifiques --- r_associated #0: 5 --> dysgammaglobulinémie n1=faible réponse proliférative des lymphocytes T aux antigènes spécifiques | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 gammapathie --- r_associated #0: 5 --> dysgammaglobulinémie n1=gammapathie | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 hypogammaglobulinémie --- r_associated #0: 5 --> dysgammaglobulinémie n1=hypogammaglobulinémie | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 immunodéficience des lymphocytes B --- r_associated #0: 5 --> dysgammaglobulinémie n1=immunodéficience des lymphocytes B | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 lymphocytes normaux ou élevés --- r_associated #0: 5 --> dysgammaglobulinémie n1=lymphocytes normaux ou élevés | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 nombre normal de lymphocytes circulants --- r_associated #0: 5 --> dysgammaglobulinémie n1=nombre normal de lymphocytes circulants | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 nombres normaux de lymphocytes --- r_associated #0: 5 --> dysgammaglobulinémie n1=nombres normaux de lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 nombres normaux de lymphocytes B CD19+ --- r_associated #0: 5 --> dysgammaglobulinémie n1=nombres normaux de lymphocytes B CD19+ | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 nombres normaux de lymphocytes et de cellules NK --- r_associated #0: 5 --> dysgammaglobulinémie n1=nombres normaux de lymphocytes et de cellules NK | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 proportion de lymphocytes T fortement diminuée --- r_associated #0: 5 --> dysgammaglobulinémie n1=proportion de lymphocytes T fortement diminuée | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 réduction de la numération des lymphocytes T CD3 --- r_associated #0: 5 --> dysgammaglobulinémie n1=réduction de la numération des lymphocytes T CD3 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 réduction de la numération des lymphocytes T CD4 --- r_associated #0: 5 --> dysgammaglobulinémie n1=réduction de la numération des lymphocytes T CD4 | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 réduction de la production d'interleukine 2 par les lymphocytes sanguins stimulés par des mitogènes --- r_associated #0: 5 --> dysgammaglobulinémie n1=réduction de la production d'interleukine 2 par les lymphocytes sanguins stimulés par des mitogènes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 réponse lymphocytaire normale au mitogène pokeweed et à la concanavaline A --- r_associated #0: 5 --> dysgammaglobulinémie n1=réponse lymphocytaire normale au mitogène pokeweed et à la concanavaline A | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 réponse proliférative altérée des lymphocytes à la malignité --- r_associated #0: 5 --> dysgammaglobulinémie n1=réponse proliférative altérée des lymphocytes à la malignité | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 septicémie du nouveau-né --- r_associated #0: 5 --> dysgammaglobulinémie n1=septicémie du nouveau-né | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 septicémie néonatale --- r_associated #0: 5 --> dysgammaglobulinémie n1=septicémie néonatale | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5 signalisation intracellulaire défectueuse dans les lymphocytes --- r_associated #0: 5 --> dysgammaglobulinémie n1=signalisation intracellulaire défectueuse dans les lymphocytes | n2=dysgammaglobulinémie | rel=r_associated | relid=0 | w=5